id	sid	tid	token	lemma	pos
ajlm-289	1	1	article	article	PROPN
ajlm-289	1	2	information	information	NOUN
ajlm-289	1	3	authors	author	NOUN
ajlm-289	1	4	:	:	PUNCT
ajlm-289	1	5	robyn	robyn	PROPN
ajlm-289	1	6	marshall1,2	marshall1,2	PROPN
ajlm-289	1	7	jenifer	jenifer	NOUN
ajlm-289	2	1	vaughan1,2	vaughan1,2	PROPN
ajlm-289	2	2	ria	ria	PROPN
ajlm-289	2	3	david1,3	david1,3	PROPN
ajlm-289	2	4	elise	elise	PROPN
ajlm-289	2	5	schapkaitz1,2	schapkaitz1,2	PROPN
ajlm-289	2	6	sergio	sergio	PROPN
ajlm-289	2	7	carmona1,2	carmona1,2	PROPN
ajlm-289	2	8	tracey	tracey	PROPN
ajlm-289	2	9	wiggill1,2	wiggill1,2	PROPN
ajlm-289	2	10	affiliations	affiliation	NOUN
ajlm-289	2	11	:	:	PUNCT
ajlm-289	2	12	1department	1department	NUM
ajlm-289	2	13	of	of	ADP
ajlm-289	2	14	molecular	molecular	ADJ
ajlm-289	2	15	medicine	medicine	NOUN
ajlm-289	2	16	and	and	CCONJ
ajlm-289	2	17	haematology	haematology	NOUN
ajlm-289	2	18	,	,	PUNCT
ajlm-289	2	19	university	university	NOUN
ajlm-289	2	20	of	of	ADP
ajlm-289	2	21	the	the	DET
ajlm-289	2	22	witwatersrand	witwatersrand	NOUN
ajlm-289	2	23	,	,	PUNCT
ajlm-289	2	24	johannesburg	johannesburg	PROPN
ajlm-289	2	25	,	,	PUNCT
ajlm-289	2	26	south	south	PROPN
ajlm-289	2	27	africa	africa	PROPN
ajlm-289	3	1	2national	2national	NUM
ajlm-289	3	2	health	health	PROPN
ajlm-289	3	3	laboratory	laboratory	NOUN
ajlm-289	3	4	service	service	PROPN
ajlm-289	3	5	,	,	PUNCT
ajlm-289	3	6	johannesburg	johannesburg	PROPN
ajlm-289	3	7	,	,	PUNCT
ajlm-289	3	8	south	south	PROPN
ajlm-289	3	9	africa	africa	PROPN
ajlm-289	3	10	3division	3division	NUM
ajlm-289	3	11	of	of	ADP
ajlm-289	3	12	medical	medical	ADJ
ajlm-289	3	13	oncology	oncology	NOUN
ajlm-289	3	14	,	,	PUNCT
ajlm-289	3	15	department	department	NOUN
ajlm-289	3	16	of	of	ADP
ajlm-289	3	17	internal	internal	ADJ
ajlm-289	3	18	medicine	medicine	NOUN
ajlm-289	3	19	,	,	PUNCT
ajlm-289	3	20	university	university	NOUN
ajlm-289	3	21	of	of	ADP
ajlm-289	3	22	the	the	DET
ajlm-289	3	23	witwatersrand	witwatersrand	NOUN
ajlm-289	3	24	,	,	PUNCT
ajlm-289	3	25	johannesburg	johannesburg	PROPN
ajlm-289	3	26	,	,	PUNCT
ajlm-289	3	27	south	south	PROPN
ajlm-289	3	28	africa	africa	PROPN
ajlm-289	3	29	correspondence	correspondence	NOUN
ajlm-289	3	30	to	to	ADP
ajlm-289	3	31	:	:	PUNCT
ajlm-289	3	32	robyn	robyn	PROPN
ajlm-289	3	33	marshall	marshall	PROPN
ajlm-289	3	34	email	email	PROPN
ajlm-289	3	35	:	:	PUNCT
ajlm-289	3	36	dr.rmarshall@gmail.com	dr.rmarshall@gmail.com	PROPN
ajlm-289	3	37	postal	postal	ADJ
ajlm-289	3	38	address	address	NOUN
ajlm-289	3	39	:	:	PUNCT
ajlm-289	3	40	university	university	NOUN
ajlm-289	3	41	of	of	ADP
ajlm-289	3	42	the	the	DET
ajlm-289	3	43	witwatersrand	witwatersrand	PROPN
ajlm-289	3	44	medical	medical	PROPN
ajlm-289	3	45	school	school	PROPN
ajlm-289	3	46	,	,	PUNCT
ajlm-289	3	47	room	room	NOUN
ajlm-289	3	48	3b22	3b22	PROPN
ajlm-289	3	49	,	,	PUNCT
ajlm-289	3	50	7	7	NUM
ajlm-289	3	51	york	york	PROPN
ajlm-289	3	52	road	road	NOUN
ajlm-289	3	53	,	,	PUNCT
ajlm-289	3	54	johannesburg	johannesburg	PROPN
ajlm-289	3	55	,	,	PUNCT
ajlm-289	3	56	south	south	PROPN
ajlm-289	3	57	africa	africa	PROPN
ajlm-289	3	58	dates	date	NOUN
ajlm-289	3	59	:	:	PUNCT
ajlm-289	3	60	received	receive	VERB
ajlm-289	3	61	:	:	PUNCT
ajlm-289	3	62	11	11	NUM
ajlm-289	3	63	dec	dec	PROPN
ajlm-289	3	64	.	.	PROPN
ajlm-289	3	65	2014	2014	NUM
ajlm-289	3	66	accepted	accept	VERB
ajlm-289	3	67	:	:	PUNCT
ajlm-289	3	68	18	18	NUM
ajlm-289	3	69	aug	aug	PROPN
ajlm-289	3	70	.	.	PROPN
ajlm-289	3	71	2015	2015	NUM
ajlm-289	3	72	published	publish	VERB
ajlm-289	3	73	:	:	PUNCT
ajlm-289	3	74	23	23	NUM
ajlm-289	3	75	nov	nov	NOUN
ajlm-289	3	76	.	.	PROPN
ajlm-289	3	77	2015	2015	NUM
ajlm-289	3	78	how	how	SCONJ
ajlm-289	3	79	to	to	PART
ajlm-289	3	80	cite	cite	VERB
ajlm-289	3	81	this	this	DET
ajlm-289	3	82	article	article	NOUN
ajlm-289	3	83	:	:	PUNCT
ajlm-289	3	84	marshall	marshall	PROPN
ajlm-289	3	85	r	r	PROPN
ajlm-289	3	86	,	,	PUNCT
ajlm-289	3	87	vaughan	vaughan	PROPN
ajlm-289	3	88	j	j	PROPN
ajlm-289	3	89	,	,	PUNCT
ajlm-289	3	90	david	david	PROPN
ajlm-289	3	91	r	r	PROPN
ajlm-289	3	92	,	,	PUNCT
ajlm-289	3	93	schapkaitz	schapkaitz	PROPN
ajlm-289	3	94	e	e	PROPN
ajlm-289	3	95	,	,	PUNCT
ajlm-289	3	96	carmona	carmona	PROPN
ajlm-289	3	97	s	s	PROPN
ajlm-289	3	98	,	,	PUNCT
ajlm-289	3	99	wiggill	wiggill	PROPN
ajlm-289	3	100	t.	t.	PROPN
ajlm-289	3	101	primary	primary	ADJ
ajlm-289	3	102	plasma	plasma	NOUN
ajlm-289	3	103	cell	cell	NOUN
ajlm-289	3	104	leukaemia	leukaemia	NOUN
ajlm-289	3	105	in	in	ADP
ajlm-289	3	106	a	a	DET
ajlm-289	3	107	22	22	NUM
ajlm-289	3	108	-	-	PUNCT
ajlm-289	3	109	year	year	NOUN
ajlm-289	3	110	-	-	PUNCT
ajlm-289	3	111	old	old	ADJ
ajlm-289	3	112	woman	woman	NOUN
ajlm-289	3	113	:	:	PUNCT
ajlm-289	3	114	a	a	DET
ajlm-289	3	115	case	case	NOUN
ajlm-289	3	116	report	report	NOUN
ajlm-289	3	117	.	.	PUNCT
ajlm-289	4	1	afr	afr	PROPN
ajlm-289	4	2	j	j	PROPN
ajlm-289	4	3	lab	lab	PROPN
ajlm-289	4	4	med	med	PROPN
ajlm-289	4	5	.	.	PUNCT
ajlm-289	4	6	2015;4(1	2015;4(1	NOUN
ajlm-289	4	7	)	)	PUNCT
ajlm-289	4	8	,	,	PUNCT
ajlm-289	4	9	art	art	NOUN
ajlm-289	4	10	.	.	PUNCT
ajlm-289	5	1	#	#	SYM
ajlm-289	5	2	289	289	NUM
ajlm-289	5	3	,	,	PUNCT
ajlm-289	5	4	5	5	NUM
ajlm-289	5	5	pages	page	NOUN
ajlm-289	5	6	.	.	PUNCT
ajlm-289	6	1	http://dx.doi.org/10.4102/ajlm.v4i1.289	http://dx.doi.org/10.4102/ajlm.v4i1.289	ADJ
ajlm-289	6	2	copyright	copyright	NOUN
ajlm-289	6	3	notice	notice	NOUN
ajlm-289	6	4	:	:	PUNCT
ajlm-289	6	5	©	©	PROPN
ajlm-289	6	6	2015	2015	NUM
ajlm-289	6	7	.	.	PUNCT
ajlm-289	7	1	the	the	DET
ajlm-289	7	2	authors	author	NOUN
ajlm-289	7	3	.	.	PUNCT
ajlm-289	8	1	licensee	licensee	NOUN
ajlm-289	8	2	:	:	PUNCT
ajlm-289	8	3	aosis	aosis	NOUN
ajlm-289	8	4	openjournals	openjournal	NOUN
ajlm-289	8	5	.	.	PUNCT
ajlm-289	9	1	this	this	PRON
ajlm-289	9	2	is	be	AUX
ajlm-289	9	3	an	an	DET
ajlm-289	9	4	open	open	ADJ
ajlm-289	9	5	access	access	NOUN
ajlm-289	9	6	article	article	NOUN
ajlm-289	9	7	distributed	distribute	VERB
ajlm-289	9	8	under	under	ADP
ajlm-289	9	9	the	the	DET
ajlm-289	9	10	terms	term	NOUN
ajlm-289	9	11	of	of	ADP
ajlm-289	9	12	the	the	DET
ajlm-289	9	13	creative	creative	ADJ
ajlm-289	9	14	commons	common	NOUN
ajlm-289	9	15	attribution	attribution	NOUN
ajlm-289	9	16	license	license	NOUN
ajlm-289	9	17	,	,	PUNCT
ajlm-289	9	18	which	which	PRON
ajlm-289	9	19	permits	permit	VERB
ajlm-289	9	20	unrestricted	unrestricted	ADJ
ajlm-289	9	21	use	use	NOUN
ajlm-289	9	22	,	,	PUNCT
ajlm-289	9	23	distribution	distribution	NOUN
ajlm-289	9	24	,	,	PUNCT
ajlm-289	9	25	and	and	CCONJ
ajlm-289	9	26	reproduction	reproduction	NOUN
ajlm-289	9	27	in	in	ADP
ajlm-289	9	28	any	any	DET
ajlm-289	9	29	medium	medium	NOUN
ajlm-289	9	30	,	,	PUNCT
ajlm-289	9	31	provided	provide	VERB
ajlm-289	9	32	the	the	DET
ajlm-289	9	33	original	original	ADJ
ajlm-289	9	34	work	work	NOUN
ajlm-289	9	35	is	be	AUX
ajlm-289	9	36	properly	properly	ADV
ajlm-289	9	37	cited	cite	VERB
ajlm-289	9	38	.	.	PUNCT
ajlm-289	10	1	primary	primary	ADJ
ajlm-289	10	2	plasma	plasma	NOUN
ajlm-289	10	3	cell	cell	NOUN
ajlm-289	10	4	leukaemia	leukaemia	NOUN
ajlm-289	10	5	in	in	ADP
ajlm-289	10	6	a	a	DET
ajlm-289	10	7	22	22	NUM
ajlm-289	10	8	-	-	PUNCT
ajlm-289	10	9	year	year	NOUN
ajlm-289	10	10	-	-	PUNCT
ajlm-289	10	11	old	old	ADJ
ajlm-289	10	12	woman	woman	NOUN
ajlm-289	10	13	:	:	PUNCT
ajlm-289	10	14	a	a	DET
ajlm-289	10	15	case	case	NOUN
ajlm-289	10	16	report	report	NOUN
ajlm-289	10	17	in	in	ADP
ajlm-289	10	18	this	this	DET
ajlm-289	10	19	case	case	NOUN
ajlm-289	10	20	studies	study	NOUN
ajlm-289	10	21	...	...	PUNCT
ajlm-289	10	22	open	open	ADJ
ajlm-289	10	23	access	access	NOUN
ajlm-289	10	24	•	•	ADP
ajlm-289	10	25	abstract	abstract	ADJ
ajlm-289	10	26	•	•	NUM
ajlm-289	10	27	introduction	introduction	NOUN
ajlm-289	10	28	•	•	ADP
ajlm-289	10	29	ethical	ethical	ADJ
ajlm-289	10	30	considerations	consideration	NOUN
ajlm-289	10	31	   	   	SPACE
ajlm-289	10	32	•	•	NUM
ajlm-289	10	33	potential	potential	ADJ
ajlm-289	10	34	benefits	benefit	NOUN
ajlm-289	10	35	and	and	CCONJ
ajlm-289	10	36	hazards	hazard	NOUN
ajlm-289	10	37	   	   	SPACE
ajlm-289	10	38	•	•	NUM
ajlm-289	10	39	recruitment	recruitment	NOUN
ajlm-289	10	40	procedures	procedure	NOUN
ajlm-289	10	41	   	   	SPACE
ajlm-289	10	42	•	•	NUM
ajlm-289	10	43	informed	informed	ADJ
ajlm-289	10	44	consent	consent	NOUN
ajlm-289	10	45	   	   	SPACE
ajlm-289	10	46	•	•	NOUN
ajlm-289	11	1	data	datum	NOUN
ajlm-289	11	2	protection	protection	NOUN
ajlm-289	11	3	•	•	NOUN
ajlm-289	11	4	case	case	NOUN
ajlm-289	11	5	presentation	presentation	NOUN
ajlm-289	11	6	•	•	NOUN
ajlm-289	11	7	management	management	NOUN
ajlm-289	11	8	and	and	CCONJ
ajlm-289	11	9	outcome	outcome	VERB
ajlm-289	11	10	•	•	NUM
ajlm-289	11	11	discussion	discussion	NOUN
ajlm-289	11	12	•	•	NOUN
ajlm-289	11	13	acknowledgements	acknowledgement	NOUN
ajlm-289	11	14	   	   	SPACE
ajlm-289	11	15	•	•	NOUN
ajlm-289	11	16	competing	compete	VERB
ajlm-289	11	17	interests	interest	NOUN
ajlm-289	11	18	   	   	SPACE
ajlm-289	11	19	•	•	NUM
ajlm-289	11	20	authors	author	NOUN
ajlm-289	11	21	’	'	PUNCT
ajlm-289	11	22	contributions	contribution	NOUN
ajlm-289	11	23	•	•	NUM
ajlm-289	11	24	references	reference	NOUN
ajlm-289	11	25	abstract	abstract	ADJ
ajlm-289	11	26	top	top	PROPN
ajlm-289	11	27	↑	↑	PROPN
ajlm-289	11	28	introduction	introduction	NOUN
ajlm-289	11	29	:	:	PUNCT
ajlm-289	11	30	primary	primary	ADJ
ajlm-289	11	31	plasma	plasma	NOUN
ajlm-289	11	32	cell	cell	NOUN
ajlm-289	11	33	leukaemia	leukaemia	NOUN
ajlm-289	11	34	is	be	AUX
ajlm-289	11	35	a	a	DET
ajlm-289	11	36	rare	rare	ADJ
ajlm-289	11	37	and	and	CCONJ
ajlm-289	11	38	highly	highly	ADV
ajlm-289	11	39	aggressive	aggressive	ADJ
ajlm-289	11	40	disease	disease	NOUN
ajlm-289	11	41	that	that	PRON
ajlm-289	11	42	is	be	AUX
ajlm-289	11	43	commonly	commonly	ADV
ajlm-289	11	44	diagnosed	diagnose	VERB
ajlm-289	11	45	a	a	DET
ajlm-289	11	46	decade	decade	NOUN
ajlm-289	11	47	earlier	early	ADV
ajlm-289	11	48	than	than	ADP
ajlm-289	11	49	multiple	multiple	ADJ
ajlm-289	11	50	myeloma	myeloma	NOUN
ajlm-289	11	51	,	,	PUNCT
ajlm-289	11	52	at	at	ADP
ajlm-289	11	53	a	a	DET
ajlm-289	11	54	median	median	ADJ
ajlm-289	11	55	age	age	NOUN
ajlm-289	11	56	of	of	ADP
ajlm-289	11	57	55	55	NUM
ajlm-289	11	58	years	year	NOUN
ajlm-289	11	59	.	.	PUNCT
ajlm-289	12	1	however	however	ADV
ajlm-289	12	2	,	,	PUNCT
ajlm-289	12	3	it	it	PRON
ajlm-289	12	4	has	have	AUX
ajlm-289	12	5	also	also	ADV
ajlm-289	12	6	been	be	AUX
ajlm-289	12	7	described	describe	VERB
ajlm-289	12	8	in	in	ADP
ajlm-289	12	9	younger	young	ADJ
ajlm-289	12	10	patients	patient	NOUN
ajlm-289	12	11	,	,	PUNCT
ajlm-289	12	12	as	as	SCONJ
ajlm-289	12	13	documented	document	VERB
ajlm-289	12	14	in	in	ADP
ajlm-289	12	15	this	this	DET
ajlm-289	12	16	case	case	NOUN
ajlm-289	12	17	report	report	NOUN
ajlm-289	12	18	.	.	PUNCT
ajlm-289	13	1	it	it	PRON
ajlm-289	13	2	often	often	ADV
ajlm-289	13	3	presents	present	VERB
ajlm-289	13	4	with	with	ADP
ajlm-289	13	5	hepatosplenomegaly	hepatosplenomegaly	NOUN
ajlm-289	13	6	and	and	CCONJ
ajlm-289	13	7	lymphadenopathy	lymphadenopathy	ADJ
ajlm-289	13	8	,	,	PUNCT
ajlm-289	13	9	whilst	whilst	SCONJ
ajlm-289	13	10	the	the	DET
ajlm-289	13	11	presence	presence	NOUN
ajlm-289	13	12	of	of	ADP
ajlm-289	13	13	bony	bony	NOUN
ajlm-289	13	14	lesions	lesion	NOUN
ajlm-289	13	15	are	be	AUX
ajlm-289	13	16	less	less	ADV
ajlm-289	13	17	-	-	PUNCT
ajlm-289	13	18	commonly	commonly	ADV
ajlm-289	13	19	seen	see	VERB
ajlm-289	13	20	when	when	SCONJ
ajlm-289	13	21	compared	compare	VERB
ajlm-289	13	22	to	to	ADP
ajlm-289	13	23	multiple	multiple	ADJ
ajlm-289	13	24	myeloma	myeloma	NOUN
ajlm-289	13	25	.	.	PUNCT
ajlm-289	14	1	case	case	NOUN
ajlm-289	14	2	presentation	presentation	NOUN
ajlm-289	14	3	:	:	PUNCT
ajlm-289	14	4	this	this	DET
ajlm-289	14	5	report	report	NOUN
ajlm-289	14	6	describes	describe	VERB
ajlm-289	14	7	the	the	DET
ajlm-289	14	8	case	case	NOUN
ajlm-289	14	9	of	of	ADP
ajlm-289	14	10	a	a	DET
ajlm-289	14	11	young	young	ADJ
ajlm-289	14	12	woman	woman	NOUN
ajlm-289	14	13	who	who	PRON
ajlm-289	14	14	presented	present	VERB
ajlm-289	14	15	with	with	ADP
ajlm-289	14	16	symptoms	symptom	NOUN
ajlm-289	14	17	of	of	ADP
ajlm-289	14	18	anaemia	anaemia	NOUN
ajlm-289	14	19	and	and	CCONJ
ajlm-289	14	20	a	a	DET
ajlm-289	14	21	history	history	NOUN
ajlm-289	14	22	of	of	ADP
ajlm-289	14	23	menorrhagia	menorrhagia	NOUN
ajlm-289	14	24	.	.	PUNCT
ajlm-289	15	1	on	on	ADP
ajlm-289	15	2	further	further	ADJ
ajlm-289	15	3	careful	careful	ADJ
ajlm-289	15	4	examination	examination	NOUN
ajlm-289	15	5	,	,	PUNCT
ajlm-289	15	6	she	she	PRON
ajlm-289	15	7	was	be	AUX
ajlm-289	15	8	found	find	VERB
ajlm-289	15	9	to	to	PART
ajlm-289	15	10	have	have	VERB
ajlm-289	15	11	additional	additional	ADJ
ajlm-289	15	12	signs	sign	NOUN
ajlm-289	15	13	and	and	CCONJ
ajlm-289	15	14	symptoms	symptom	NOUN
ajlm-289	15	15	and	and	CCONJ
ajlm-289	15	16	was	be	AUX
ajlm-289	15	17	later	later	ADV
ajlm-289	15	18	diagnosed	diagnose	VERB
ajlm-289	15	19	with	with	ADP
ajlm-289	15	20	primary	primary	ADJ
ajlm-289	15	21	plasma	plasma	NOUN
ajlm-289	15	22	cell	cell	NOUN
ajlm-289	15	23	leukaemia	leukaemia	NOUN
ajlm-289	15	24	.	.	PUNCT
ajlm-289	16	1	management	management	NOUN
ajlm-289	16	2	and	and	CCONJ
ajlm-289	16	3	outcome	outcome	NOUN
ajlm-289	16	4	:	:	PUNCT
ajlm-289	16	5	on	on	ADP
ajlm-289	16	6	admission	admission	NOUN
ajlm-289	16	7	,	,	PUNCT
ajlm-289	16	8	the	the	DET
ajlm-289	16	9	patient	patient	NOUN
ajlm-289	16	10	received	receive	VERB
ajlm-289	16	11	supportive	supportive	ADJ
ajlm-289	16	12	care	care	NOUN
ajlm-289	16	13	measures	measure	NOUN
ajlm-289	16	14	,	,	PUNCT
ajlm-289	16	15	including	include	VERB
ajlm-289	16	16	blood	blood	NOUN
ajlm-289	16	17	products	product	NOUN
ajlm-289	16	18	.	.	PUNCT
ajlm-289	17	1	at	at	ADP
ajlm-289	17	2	diagnosis	diagnosis	NOUN
ajlm-289	17	3	,	,	PUNCT
ajlm-289	17	4	a	a	DET
ajlm-289	17	5	specific	specific	ADJ
ajlm-289	17	6	chemotherapy	chemotherapy	NOUN
ajlm-289	17	7	regimen	regimen	NOUN
ajlm-289	17	8	was	be	AUX
ajlm-289	17	9	commenced	commence	VERB
ajlm-289	17	10	;	;	PUNCT
ajlm-289	17	11	however	however	ADV
ajlm-289	17	12	,	,	PUNCT
ajlm-289	17	13	this	this	PRON
ajlm-289	17	14	failed	fail	VERB
ajlm-289	17	15	to	to	PART
ajlm-289	17	16	induce	induce	VERB
ajlm-289	17	17	remission	remission	NOUN
ajlm-289	17	18	.	.	PUNCT
ajlm-289	18	1	the	the	DET
ajlm-289	18	2	decision	decision	NOUN
ajlm-289	18	3	to	to	PART
ajlm-289	18	4	continue	continue	VERB
ajlm-289	18	5	with	with	ADP
ajlm-289	18	6	supportive	supportive	ADJ
ajlm-289	18	7	care	care	NOUN
ajlm-289	18	8	only	only	ADV
ajlm-289	18	9	was	be	AUX
ajlm-289	18	10	made	make	VERB
ajlm-289	18	11	and	and	CCONJ
ajlm-289	18	12	the	the	DET
ajlm-289	18	13	patient	patient	NOUN
ajlm-289	18	14	died	die	VERB
ajlm-289	18	15	seven	seven	NUM
ajlm-289	18	16	months	month	NOUN
ajlm-289	18	17	later	later	ADV
ajlm-289	18	18	.	.	PUNCT
ajlm-289	19	1	discussion	discussion	NOUN
ajlm-289	19	2	:	:	PUNCT
ajlm-289	19	3	this	this	DET
ajlm-289	19	4	case	case	NOUN
ajlm-289	19	5	study	study	NOUN
ajlm-289	19	6	is	be	AUX
ajlm-289	19	7	presented	present	VERB
ajlm-289	19	8	because	because	SCONJ
ajlm-289	19	9	of	of	ADP
ajlm-289	19	10	its	its	PRON
ajlm-289	19	11	rarity	rarity	NOUN
ajlm-289	19	12	,	,	PUNCT
ajlm-289	19	13	the	the	DET
ajlm-289	19	14	young	young	ADJ
ajlm-289	19	15	age	age	NOUN
ajlm-289	19	16	of	of	ADP
ajlm-289	19	17	the	the	DET
ajlm-289	19	18	patient	patient	NOUN
ajlm-289	19	19	at	at	ADP
ajlm-289	19	20	presentation	presentation	NOUN
ajlm-289	19	21	and	and	CCONJ
ajlm-289	19	22	the	the	DET
ajlm-289	19	23	unusual	unusual	ADJ
ajlm-289	19	24	clinical	clinical	ADJ
ajlm-289	19	25	and	and	CCONJ
ajlm-289	19	26	laboratory	laboratory	NOUN
ajlm-289	19	27	findings	finding	NOUN
ajlm-289	19	28	.	.	PUNCT
ajlm-289	20	1	persistent	persistent	ADJ
ajlm-289	20	2	anaemia	anaemia	NOUN
ajlm-289	20	3	unresponsive	unresponsive	ADJ
ajlm-289	20	4	to	to	ADP
ajlm-289	20	5	standard	standard	ADJ
ajlm-289	20	6	treatment	treatment	NOUN
ajlm-289	20	7	should	should	AUX
ajlm-289	20	8	raise	raise	VERB
ajlm-289	20	9	the	the	DET
ajlm-289	20	10	index	index	NOUN
ajlm-289	20	11	of	of	ADP
ajlm-289	20	12	suspicion	suspicion	NOUN
ajlm-289	20	13	and	and	CCONJ
ajlm-289	20	14	further	further	ADJ
ajlm-289	20	15	investigations	investigation	NOUN
ajlm-289	20	16	directed	direct	VERB
ajlm-289	20	17	to	to	PART
ajlm-289	20	18	exclude	exclude	VERB
ajlm-289	20	19	malignancies	malignancy	NOUN
ajlm-289	20	20	should	should	AUX
ajlm-289	20	21	be	be	AUX
ajlm-289	20	22	considered	consider	VERB
ajlm-289	20	23	.	.	PUNCT
ajlm-289	21	1	introduction	introduction	NOUN
ajlm-289	21	2	top	top	PROPN
ajlm-289	21	3	↑	↑	PROPN
ajlm-289	21	4	plasma	plasma	NOUN
ajlm-289	21	5	cell	cell	NOUN
ajlm-289	21	6	leukaemia	leukaemia	NOUN
ajlm-289	21	7	(	(	PUNCT
ajlm-289	21	8	pcl	pcl	PROPN
ajlm-289	21	9	)	)	PUNCT
ajlm-289	21	10	is	be	AUX
ajlm-289	21	11	a	a	DET
ajlm-289	21	12	rare	rare	ADJ
ajlm-289	21	13	and	and	CCONJ
ajlm-289	21	14	aggressive	aggressive	ADJ
ajlm-289	21	15	plasma	plasma	NOUN
ajlm-289	21	16	cell	cell	NOUN
ajlm-289	21	17	dyscrasia,1	dyscrasia,1	NOUN
ajlm-289	21	18	which	which	PRON
ajlm-289	21	19	is	be	AUX
ajlm-289	21	20	divided	divide	VERB
ajlm-289	21	21	into	into	ADP
ajlm-289	21	22	primary	primary	ADJ
ajlm-289	21	23	and	and	CCONJ
ajlm-289	21	24	secondary	secondary	ADJ
ajlm-289	21	25	subtypes	subtype	NOUN
ajlm-289	21	26	.	.	PUNCT
ajlm-289	22	1	the	the	DET
ajlm-289	22	2	distinction	distinction	NOUN
ajlm-289	22	3	from	from	ADP
ajlm-289	22	4	multiple	multiple	ADJ
ajlm-289	22	5	myeloma	myeloma	NOUN
ajlm-289	22	6	(	(	PUNCT
ajlm-289	22	7	mm	mm	NOUN
ajlm-289	22	8	)	)	PUNCT
ajlm-289	22	9	and	and	CCONJ
ajlm-289	22	10	other	other	ADJ
ajlm-289	22	11	plasma	plasma	NOUN
ajlm-289	22	12	cell	cell	NOUN
ajlm-289	22	13	dyscrasia	dyscrasia	PROPN
ajlm-289	22	14	is	be	AUX
ajlm-289	22	15	based	base	VERB
ajlm-289	22	16	on	on	ADP
ajlm-289	22	17	the	the	DET
ajlm-289	22	18	presence	presence	NOUN
ajlm-289	22	19	of	of	ADP
ajlm-289	22	20	a	a	DET
ajlm-289	22	21	circulating	circulate	VERB
ajlm-289	22	22	peripheral	peripheral	ADJ
ajlm-289	22	23	blood	blood	NOUN
ajlm-289	22	24	plasma	plasma	NOUN
ajlm-289	22	25	cell	cell	NOUN
ajlm-289	22	26	count	count	NOUN
ajlm-289	22	27	of	of	ADP
ajlm-289	22	28	>	>	X
ajlm-289	22	29	20	20	NUM
ajlm-289	22	30	%	%	NOUN
ajlm-289	22	31	or	or	CCONJ
ajlm-289	22	32	>	>	SYM
ajlm-289	22	33	2	2	NUM
ajlm-289	22	34	×	×	NOUN
ajlm-289	22	35	109	109	NUM
ajlm-289	22	36	/	/	SYM
ajlm-289	22	37	l.2,3	l.2,3	PROPN
ajlm-289	22	38	primary	primary	PROPN
ajlm-289	22	39	pcl	pcl	PROPN
ajlm-289	22	40	presents	present	VERB
ajlm-289	22	41	de	de	X
ajlm-289	22	42	novo	novo	NOUN
ajlm-289	22	43	in	in	ADP
ajlm-289	22	44	the	the	DET
ajlm-289	22	45	leukaemic	leukaemic	ADJ
ajlm-289	22	46	phase	phase	NOUN
ajlm-289	22	47	and	and	CCONJ
ajlm-289	22	48	comprises	comprise	VERB
ajlm-289	22	49	60	60	NUM
ajlm-289	22	50	%	%	NOUN
ajlm-289	22	51	of	of	ADP
ajlm-289	22	52	all	all	PRON
ajlm-289	22	53	pcl.3,4	pcl.3,4	ADP
ajlm-289	22	54	it	it	PRON
ajlm-289	22	55	has	have	VERB
ajlm-289	22	56	a	a	DET
ajlm-289	22	57	median	median	ADJ
ajlm-289	22	58	age	age	NOUN
ajlm-289	22	59	of	of	ADP
ajlm-289	22	60	diagnosis	diagnosis	NOUN
ajlm-289	22	61	of	of	ADP
ajlm-289	22	62	55	55	NUM
ajlm-289	22	63	years	year	NOUN
ajlm-289	22	64	,	,	PUNCT
ajlm-289	22	65	a	a	DET
ajlm-289	22	66	decade	decade	NOUN
ajlm-289	22	67	earlier	early	ADV
ajlm-289	22	68	than	than	ADP
ajlm-289	22	69	mm	mm	NOUN
ajlm-289	22	70	and	and	CCONJ
ajlm-289	22	71	secondary	secondary	PROPN
ajlm-289	22	72	pcl	pcl	PROPN
ajlm-289	22	73	,	,	PUNCT
ajlm-289	22	74	with	with	ADP
ajlm-289	22	75	the	the	DET
ajlm-289	22	76	symptoms	symptom	NOUN
ajlm-289	22	77	often	often	ADV
ajlm-289	22	78	mimicking	mimic	VERB
ajlm-289	22	79	those	those	PRON
ajlm-289	22	80	of	of	ADP
ajlm-289	22	81	acute	acute	PROPN
ajlm-289	22	82	leukaemia.5	leukaemia.5	PROPN
ajlm-289	22	83	prognostic	prognostic	ADJ
ajlm-289	22	84	parameters	parameter	NOUN
ajlm-289	22	85	include	include	VERB
ajlm-289	22	86	a	a	DET
ajlm-289	22	87	low	low	ADJ
ajlm-289	22	88	serum	serum	NOUN
ajlm-289	22	89	albumin	albumin	NOUN
ajlm-289	22	90	;	;	PUNCT
ajlm-289	22	91	hypercalcaemia	hypercalcaemia	NOUN
ajlm-289	22	92	and	and	CCONJ
ajlm-289	22	93	elevated	elevated	ADJ
ajlm-289	22	94	β2	β2	PROPN
ajlm-289	22	95	microglobulin	microglobulin	PROPN
ajlm-289	22	96	,	,	PUNCT
ajlm-289	22	97	serum	serum	NOUN
ajlm-289	22	98	lactate	lactate	NOUN
ajlm-289	22	99	dehydrogenase	dehydrogenase	NOUN
ajlm-289	22	100	and	and	CCONJ
ajlm-289	22	101	serum	serum	NOUN
ajlm-289	22	102	c	c	NOUN
ajlm-289	22	103	-	-	PUNCT
ajlm-289	22	104	reactive	reactive	ADJ
ajlm-289	22	105	protein	protein	NOUN
ajlm-289	22	106	;	;	PUNCT
ajlm-289	22	107	an	an	DET
ajlm-289	22	108	absolute	absolute	ADJ
ajlm-289	22	109	peripheral	peripheral	ADJ
ajlm-289	22	110	blood	blood	NOUN
ajlm-289	22	111	plasma	plasma	NOUN
ajlm-289	22	112	cell	cell	NOUN
ajlm-289	22	113	count	count	NOUN
ajlm-289	22	114	of	of	ADP
ajlm-289	22	115	>	>	X
ajlm-289	22	116	4	4	NUM
ajlm-289	22	117	×	×	NOUN
ajlm-289	22	118	109	109	NUM
ajlm-289	22	119	/	/	SYM
ajlm-289	22	120	l	l	NOUN
ajlm-289	22	121	;	;	PUNCT
ajlm-289	22	122	thrombocytopenia	thrombocytopenia	NOUN
ajlm-289	22	123	and	and	CCONJ
ajlm-289	22	124	an	an	DET
ajlm-289	22	125	increased	increase	VERB
ajlm-289	22	126	percentage	percentage	NOUN
ajlm-289	22	127	of	of	ADP
ajlm-289	22	128	s	s	NOUN
ajlm-289	22	129	-	-	PUNCT
ajlm-289	22	130	phase	phase	NOUN
ajlm-289	22	131	plasma	plasma	NOUN
ajlm-289	22	132	cells	cell	NOUN
ajlm-289	22	133	;	;	PUNCT
ajlm-289	22	134	advanced	advanced	ADJ
ajlm-289	22	135	age	age	NOUN
ajlm-289	22	136	(	(	PUNCT
ajlm-289	22	137	age	age	NOUN
ajlm-289	22	138	at	at	ADP
ajlm-289	22	139	diagnosis	diagnosis	NOUN
ajlm-289	22	140	of	of	ADP
ajlm-289	22	141	60	60	NUM
ajlm-289	22	142	years	year	NOUN
ajlm-289	22	143	or	or	CCONJ
ajlm-289	22	144	older	old	ADJ
ajlm-289	22	145	)	)	PUNCT
ajlm-289	22	146	and	and	CCONJ
ajlm-289	22	147	poor	poor	ADJ
ajlm-289	22	148	performance	performance	NOUN
ajlm-289	22	149	status	status	NOUN
ajlm-289	22	150	(	(	PUNCT
ajlm-289	22	151	eastern	eastern	ADJ
ajlm-289	22	152	cooperative	cooperative	ADJ
ajlm-289	22	153	oncology	oncology	NOUN
ajlm-289	22	154	group	group	NOUN
ajlm-289	22	155	grade	grade	NOUN
ajlm-289	22	156	of	of	ADP
ajlm-289	22	157	≥	≥	NOUN
ajlm-289	22	158	2),6,7	2),6,7	NOUN
ajlm-289	22	159	based	base	VERB
ajlm-289	22	160	on	on	ADP
ajlm-289	22	161	a	a	DET
ajlm-289	22	162	patient	patient	NOUN
ajlm-289	22	163	's	's	PART
ajlm-289	22	164	ability	ability	NOUN
ajlm-289	22	165	to	to	PART
ajlm-289	22	166	perform	perform	VERB
ajlm-289	22	167	the	the	DET
ajlm-289	22	168	normal	normal	ADJ
ajlm-289	22	169	activities	activity	NOUN
ajlm-289	22	170	of	of	ADP
ajlm-289	22	171	daily	daily	ADJ
ajlm-289	22	172	living	living	NOUN
ajlm-289	22	173	.	.	PUNCT
ajlm-289	23	1	specific	specific	ADJ
ajlm-289	23	2	cytogenetic	cytogenetic	ADJ
ajlm-289	23	3	results	result	NOUN
ajlm-289	23	4	associated	associate	VERB
ajlm-289	23	5	with	with	ADP
ajlm-289	23	6	lower	low	ADJ
ajlm-289	23	7	overall	overall	ADJ
ajlm-289	23	8	survival	survival	NOUN
ajlm-289	23	9	rates	rate	NOUN
ajlm-289	23	10	include	include	VERB
ajlm-289	23	11	a	a	DET
ajlm-289	23	12	complex	complex	ADJ
ajlm-289	23	13	karyotype	karyotype	NOUN
ajlm-289	23	14	,	,	PUNCT
ajlm-289	23	15	hypodiploidy	hypodiploidy	ADJ
ajlm-289	23	16	,	,	PUNCT
ajlm-289	23	17	as	as	ADV
ajlm-289	23	18	well	well	ADV
ajlm-289	23	19	as	as	ADP
ajlm-289	23	20	several	several	ADJ
ajlm-289	23	21	deletions	deletion	NOUN
ajlm-289	23	22	and	and	CCONJ
ajlm-289	23	23	translocations.6	translocations.6	PROPN
ajlm-289	23	24	ethical	ethical	ADJ
ajlm-289	23	25	considerations	consideration	NOUN
ajlm-289	23	26	top	top	ADJ
ajlm-289	23	27	↑	↑	PROPN
ajlm-289	23	28	consent	consent	NOUN
ajlm-289	23	29	was	be	AUX
ajlm-289	23	30	obtained	obtain	VERB
ajlm-289	23	31	from	from	ADP
ajlm-289	23	32	the	the	DET
ajlm-289	23	33	patient	patient	NOUN
ajlm-289	23	34	with	with	ADP
ajlm-289	23	35	ethical	ethical	ADJ
ajlm-289	23	36	clearance	clearance	NOUN
ajlm-289	23	37	from	from	ADP
ajlm-289	23	38	the	the	DET
ajlm-289	23	39	university	university	NOUN
ajlm-289	23	40	of	of	ADP
ajlm-289	23	41	the	the	DET
ajlm-289	23	42	witwatersrand	witwatersrand	NOUN
ajlm-289	23	43	human	human	PROPN
ajlm-289	23	44	research	research	PROPN
ajlm-289	23	45	ethics	ethic	NOUN
ajlm-289	23	46	committee	committee	NOUN
ajlm-289	23	47	.	.	PUNCT
ajlm-289	24	1	the	the	DET
ajlm-289	24	2	ethics	ethic	NOUN
ajlm-289	24	3	clearance	clearance	NOUN
ajlm-289	24	4	number	number	NOUN
ajlm-289	24	5	is	be	AUX
ajlm-289	24	6	m130269	m130269	NOUN
ajlm-289	24	7	.	.	PUNCT
ajlm-289	24	8	potential	potential	ADJ
ajlm-289	24	9	benefits	benefit	NOUN
ajlm-289	24	10	and	and	CCONJ
ajlm-289	24	11	hazards	hazard	NOUN
ajlm-289	24	12	there	there	PRON
ajlm-289	24	13	were	be	VERB
ajlm-289	24	14	no	no	DET
ajlm-289	24	15	risks	risk	NOUN
ajlm-289	24	16	to	to	ADP
ajlm-289	24	17	the	the	DET
ajlm-289	24	18	subject	subject	NOUN
ajlm-289	24	19	involved	involve	VERB
ajlm-289	24	20	in	in	ADP
ajlm-289	24	21	this	this	DET
ajlm-289	24	22	case	case	NOUN
ajlm-289	24	23	report	report	NOUN
ajlm-289	24	24	;	;	PUNCT
ajlm-289	24	25	and	and	CCONJ
ajlm-289	24	26	no	no	DET
ajlm-289	24	27	potential	potential	ADJ
ajlm-289	24	28	physical	physical	ADJ
ajlm-289	24	29	or	or	CCONJ
ajlm-289	24	30	psychological	psychological	ADJ
ajlm-289	24	31	dangers	danger	NOUN
ajlm-289	24	32	were	be	AUX
ajlm-289	24	33	anticipated	anticipate	VERB
ajlm-289	24	34	.	.	PUNCT
ajlm-289	25	1	there	there	PRON
ajlm-289	25	2	was	be	VERB
ajlm-289	25	3	no	no	DET
ajlm-289	25	4	perceived	perceive	VERB
ajlm-289	25	5	benefit	benefit	NOUN
ajlm-289	25	6	to	to	ADP
ajlm-289	25	7	this	this	DET
ajlm-289	25	8	patient	patient	NOUN
ajlm-289	25	9	.	.	PUNCT
ajlm-289	26	1	no	no	DET
ajlm-289	26	2	information	information	NOUN
ajlm-289	26	3	that	that	PRON
ajlm-289	26	4	could	could	AUX
ajlm-289	26	5	identify	identify	VERB
ajlm-289	26	6	the	the	DET
ajlm-289	26	7	patient	patient	NOUN
ajlm-289	26	8	has	have	AUX
ajlm-289	26	9	been	be	AUX
ajlm-289	26	10	published	publish	VERB
ajlm-289	26	11	and	and	CCONJ
ajlm-289	26	12	the	the	DET
ajlm-289	26	13	authors	author	NOUN
ajlm-289	26	14	have	have	AUX
ajlm-289	26	15	endeavoured	endeavour	VERB
ajlm-289	26	16	to	to	PART
ajlm-289	26	17	maintain	maintain	VERB
ajlm-289	26	18	the	the	DET
ajlm-289	26	19	patient	patient	NOUN
ajlm-289	26	20	's	's	PART
ajlm-289	26	21	anonymity	anonymity	NOUN
ajlm-289	26	22	.	.	PUNCT
ajlm-289	27	1	it	it	PRON
ajlm-289	27	2	is	be	AUX
ajlm-289	27	3	hoped	hope	VERB
ajlm-289	27	4	that	that	SCONJ
ajlm-289	27	5	other	other	ADJ
ajlm-289	27	6	patients	patient	NOUN
ajlm-289	27	7	with	with	ADP
ajlm-289	27	8	a	a	DET
ajlm-289	27	9	similar	similar	ADJ
ajlm-289	27	10	presentation	presentation	NOUN
ajlm-289	27	11	of	of	ADP
ajlm-289	27	12	severe	severe	ADJ
ajlm-289	27	13	anaemia	anaemia	NOUN
ajlm-289	27	14	and	and	CCONJ
ajlm-289	27	15	a	a	DET
ajlm-289	27	16	serious	serious	ADJ
ajlm-289	27	17	underlying	underlying	ADJ
ajlm-289	27	18	condition	condition	NOUN
ajlm-289	27	19	may	may	AUX
ajlm-289	27	20	be	be	AUX
ajlm-289	27	21	clinically	clinically	ADV
ajlm-289	27	22	managed	manage	VERB
ajlm-289	27	23	more	more	ADV
ajlm-289	27	24	quickly	quickly	ADV
ajlm-289	27	25	.	.	PUNCT
ajlm-289	28	1	recruitment	recruitment	NOUN
ajlm-289	28	2	procedures	procedure	NOUN
ajlm-289	28	3	as	as	SCONJ
ajlm-289	28	4	this	this	PRON
ajlm-289	28	5	was	be	AUX
ajlm-289	28	6	a	a	DET
ajlm-289	28	7	case	case	NOUN
ajlm-289	28	8	study	study	NOUN
ajlm-289	28	9	that	that	PRON
ajlm-289	28	10	highlighted	highlight	VERB
ajlm-289	28	11	a	a	DET
ajlm-289	28	12	rare	rare	ADJ
ajlm-289	28	13	and	and	CCONJ
ajlm-289	28	14	interesting	interesting	ADJ
ajlm-289	28	15	case	case	NOUN
ajlm-289	28	16	,	,	PUNCT
ajlm-289	28	17	the	the	DET
ajlm-289	28	18	patient	patient	NOUN
ajlm-289	28	19	was	be	AUX
ajlm-289	28	20	requested	request	VERB
ajlm-289	28	21	to	to	PART
ajlm-289	28	22	provide	provide	VERB
ajlm-289	28	23	consent	consent	NOUN
ajlm-289	28	24	to	to	PART
ajlm-289	28	25	make	make	VERB
ajlm-289	28	26	use	use	NOUN
ajlm-289	28	27	of	of	ADP
ajlm-289	28	28	her	her	PRON
ajlm-289	28	29	clinical	clinical	ADJ
ajlm-289	28	30	information	information	NOUN
ajlm-289	28	31	,	,	PUNCT
ajlm-289	28	32	including	include	VERB
ajlm-289	28	33	examination	examination	NOUN
ajlm-289	28	34	findings	finding	NOUN
ajlm-289	28	35	,	,	PUNCT
ajlm-289	28	36	special	special	ADJ
ajlm-289	28	37	investigation	investigation	NOUN
ajlm-289	28	38	results	result	NOUN
ajlm-289	28	39	and	and	CCONJ
ajlm-289	28	40	treatment	treatment	NOUN
ajlm-289	28	41	strategies	strategy	NOUN
ajlm-289	28	42	applied	apply	VERB
ajlm-289	28	43	.	.	PUNCT
ajlm-289	29	1	entitlement	entitlement	NOUN
ajlm-289	29	2	to	to	PART
ajlm-289	29	3	withdraw	withdraw	VERB
ajlm-289	29	4	consent	consent	NOUN
ajlm-289	29	5	would	would	AUX
ajlm-289	29	6	lapse	lapse	VERB
ajlm-289	29	7	once	once	ADV
ajlm-289	29	8	the	the	DET
ajlm-289	29	9	case	case	NOUN
ajlm-289	29	10	report	report	NOUN
ajlm-289	29	11	was	be	AUX
ajlm-289	29	12	submitted	submit	VERB
ajlm-289	29	13	for	for	ADP
ajlm-289	29	14	publication	publication	NOUN
ajlm-289	29	15	.	.	PUNCT
ajlm-289	30	1	informed	inform	VERB
ajlm-289	30	2	consent	consent	NOUN
ajlm-289	30	3	the	the	DET
ajlm-289	30	4	patient	patient	NOUN
ajlm-289	30	5	was	be	AUX
ajlm-289	30	6	requested	request	VERB
ajlm-289	30	7	to	to	PART
ajlm-289	30	8	provide	provide	VERB
ajlm-289	30	9	written	write	VERB
ajlm-289	30	10	consent	consent	NOUN
ajlm-289	30	11	to	to	PART
ajlm-289	30	12	allow	allow	VERB
ajlm-289	30	13	for	for	ADP
ajlm-289	30	14	all	all	PRON
ajlm-289	30	15	or	or	CCONJ
ajlm-289	30	16	any	any	DET
ajlm-289	30	17	part	part	NOUN
ajlm-289	30	18	of	of	ADP
ajlm-289	30	19	this	this	DET
ajlm-289	30	20	material	material	NOUN
ajlm-289	30	21	collected	collect	VERB
ajlm-289	30	22	(	(	PUNCT
ajlm-289	30	23	other	other	ADJ
ajlm-289	30	24	than	than	ADP
ajlm-289	30	25	unique	unique	ADJ
ajlm-289	30	26	patient	patient	ADJ
ajlm-289	30	27	identifiers	identifier	NOUN
ajlm-289	30	28	)	)	PUNCT
ajlm-289	30	29	to	to	PART
ajlm-289	30	30	appear	appear	VERB
ajlm-289	30	31	as	as	ADP
ajlm-289	30	32	an	an	DET
ajlm-289	30	33	abstract	abstract	NOUN
ajlm-289	30	34	,	,	PUNCT
ajlm-289	30	35	a	a	DET
ajlm-289	30	36	case	case	NOUN
ajlm-289	30	37	study	study	NOUN
ajlm-289	30	38	,	,	PUNCT
ajlm-289	30	39	or	or	CCONJ
ajlm-289	30	40	an	an	DET
ajlm-289	30	41	article	article	NOUN
ajlm-289	30	42	in	in	ADP
ajlm-289	30	43	a	a	DET
ajlm-289	30	44	journal	journal	NOUN
ajlm-289	30	45	,	,	PUNCT
ajlm-289	30	46	and	and	CCONJ
ajlm-289	30	47	any	any	DET
ajlm-289	30	48	other	other	ADJ
ajlm-289	30	49	works	work	NOUN
ajlm-289	30	50	or	or	CCONJ
ajlm-289	30	51	products	product	NOUN
ajlm-289	30	52	,	,	PUNCT
ajlm-289	30	53	in	in	ADP
ajlm-289	30	54	any	any	DET
ajlm-289	30	55	form	form	NOUN
ajlm-289	30	56	or	or	CCONJ
ajlm-289	30	57	medium	medium	NOUN
ajlm-289	30	58	.	.	PUNCT
ajlm-289	31	1	data	datum	NOUN
ajlm-289	31	2	protection	protection	VERB
ajlm-289	31	3	the	the	DET
ajlm-289	31	4	patient	patient	NOUN
ajlm-289	31	5	's	's	PART
ajlm-289	31	6	name	name	NOUN
ajlm-289	31	7	has	have	AUX
ajlm-289	31	8	not	not	PART
ajlm-289	31	9	been	be	AUX
ajlm-289	31	10	published	publish	VERB
ajlm-289	31	11	with	with	ADP
ajlm-289	31	12	the	the	DET
ajlm-289	31	13	material	material	NOUN
ajlm-289	31	14	and	and	CCONJ
ajlm-289	31	15	the	the	DET
ajlm-289	31	16	authors	author	NOUN
ajlm-289	31	17	have	have	AUX
ajlm-289	31	18	endeavoured	endeavour	VERB
ajlm-289	31	19	to	to	PART
ajlm-289	31	20	assure	assure	VERB
ajlm-289	31	21	anonymity	anonymity	NOUN
ajlm-289	31	22	.	.	PUNCT
ajlm-289	32	1	however	however	ADV
ajlm-289	32	2	,	,	PUNCT
ajlm-289	32	3	it	it	PRON
ajlm-289	32	4	is	be	AUX
ajlm-289	32	5	understood	understand	VERB
ajlm-289	32	6	that	that	SCONJ
ajlm-289	32	7	despite	despite	SCONJ
ajlm-289	32	8	the	the	DET
ajlm-289	32	9	best	good	ADJ
ajlm-289	32	10	efforts	effort	NOUN
ajlm-289	32	11	of	of	ADP
ajlm-289	32	12	the	the	DET
ajlm-289	32	13	authors	author	NOUN
ajlm-289	32	14	,	,	PUNCT
ajlm-289	32	15	the	the	DET
ajlm-289	32	16	possibility	possibility	NOUN
ajlm-289	32	17	that	that	SCONJ
ajlm-289	32	18	someone	someone	PRON
ajlm-289	32	19	,	,	PUNCT
ajlm-289	32	20	for	for	ADP
ajlm-289	32	21	example	example	NOUN
ajlm-289	32	22	,	,	PUNCT
ajlm-289	32	23	members	member	NOUN
ajlm-289	32	24	of	of	ADP
ajlm-289	32	25	the	the	DET
ajlm-289	32	26	patient	patient	NOUN
ajlm-289	32	27	's	's	PART
ajlm-289	32	28	family	family	NOUN
ajlm-289	32	29	or	or	CCONJ
ajlm-289	32	30	the	the	DET
ajlm-289	32	31	healthcare	healthcare	NOUN
ajlm-289	32	32	staff	staff	NOUN
ajlm-289	32	33	,	,	PUNCT
ajlm-289	32	34	may	may	AUX
ajlm-289	32	35	recognise	recognise	VERB
ajlm-289	32	36	the	the	DET
ajlm-289	32	37	patient	patient	NOUN
ajlm-289	32	38	from	from	ADP
ajlm-289	32	39	the	the	DET
ajlm-289	32	40	images	image	NOUN
ajlm-289	32	41	and/or	and/or	CCONJ
ajlm-289	32	42	the	the	DET
ajlm-289	32	43	accompanying	accompany	VERB
ajlm-289	32	44	text	text	NOUN
ajlm-289	32	45	.	.	PUNCT
ajlm-289	33	1	all	all	DET
ajlm-289	33	2	data	datum	NOUN
ajlm-289	33	3	collected	collect	VERB
ajlm-289	33	4	for	for	ADP
ajlm-289	33	5	this	this	DET
ajlm-289	33	6	case	case	NOUN
ajlm-289	33	7	report	report	NOUN
ajlm-289	33	8	was	be	AUX
ajlm-289	33	9	available	available	ADJ
ajlm-289	33	10	only	only	ADV
ajlm-289	33	11	to	to	ADP
ajlm-289	33	12	the	the	DET
ajlm-289	33	13	authors	author	NOUN
ajlm-289	33	14	of	of	ADP
ajlm-289	33	15	the	the	DET
ajlm-289	33	16	case	case	NOUN
ajlm-289	33	17	report	report	NOUN
ajlm-289	33	18	and	and	CCONJ
ajlm-289	33	19	no	no	DET
ajlm-289	33	20	other	other	ADJ
ajlm-289	33	21	party	party	NOUN
ajlm-289	33	22	had	have	VERB
ajlm-289	33	23	access	access	NOUN
ajlm-289	33	24	to	to	ADP
ajlm-289	33	25	any	any	PRON
ajlm-289	33	26	of	of	ADP
ajlm-289	33	27	the	the	DET
ajlm-289	33	28	patient	patient	NOUN
ajlm-289	33	29	's	's	PART
ajlm-289	33	30	individual	individual	ADJ
ajlm-289	33	31	identifiers	identifier	NOUN
ajlm-289	33	32	.	.	PUNCT
ajlm-289	34	1	case	case	NOUN
ajlm-289	34	2	presentation	presentation	NOUN
ajlm-289	34	3	top	top	NOUN
ajlm-289	34	4	↑	↑	PROPN
ajlm-289	34	5	a	a	DET
ajlm-289	34	6	22	22	NUM
ajlm-289	34	7	-	-	PUNCT
ajlm-289	34	8	year	year	NOUN
ajlm-289	34	9	-	-	PUNCT
ajlm-289	34	10	old	old	ADJ
ajlm-289	34	11	female	female	ADJ
ajlm-289	34	12	patient	patient	NOUN
ajlm-289	34	13	presented	present	VERB
ajlm-289	34	14	at	at	ADP
ajlm-289	34	15	a	a	DET
ajlm-289	34	16	peripheral	peripheral	ADJ
ajlm-289	34	17	clinic	clinic	NOUN
ajlm-289	34	18	in	in	ADP
ajlm-289	34	19	september	september	PROPN
ajlm-289	34	20	2012	2012	NUM
ajlm-289	34	21	with	with	ADP
ajlm-289	34	22	a	a	DET
ajlm-289	34	23	history	history	NOUN
ajlm-289	34	24	of	of	ADP
ajlm-289	34	25	heavy	heavy	ADJ
ajlm-289	34	26	menses	mense	NOUN
ajlm-289	34	27	after	after	ADP
ajlm-289	34	28	receiving	receive	VERB
ajlm-289	34	29	medroxyprogesterone	medroxyprogesterone	NOUN
ajlm-289	34	30	acetate	acetate	NOUN
ajlm-289	34	31	for	for	ADP
ajlm-289	34	32	contraceptive	contraceptive	ADJ
ajlm-289	34	33	purposes	purpose	NOUN
ajlm-289	34	34	in	in	ADP
ajlm-289	34	35	july	july	PROPN
ajlm-289	34	36	2012	2012	NUM
ajlm-289	34	37	.	.	PUNCT
ajlm-289	35	1	at	at	ADP
ajlm-289	35	2	this	this	DET
ajlm-289	35	3	time	time	NOUN
ajlm-289	35	4	she	she	PRON
ajlm-289	35	5	complained	complain	VERB
ajlm-289	35	6	of	of	ADP
ajlm-289	35	7	fatigue	fatigue	NOUN
ajlm-289	35	8	,	,	PUNCT
ajlm-289	35	9	dizziness	dizziness	NOUN
ajlm-289	35	10	,	,	PUNCT
ajlm-289	35	11	lower	low	ADJ
ajlm-289	35	12	back	back	ADJ
ajlm-289	35	13	pain	pain	NOUN
ajlm-289	35	14	and	and	CCONJ
ajlm-289	35	15	poor	poor	ADJ
ajlm-289	35	16	appetite	appetite	NOUN
ajlm-289	35	17	;	;	PUNCT
ajlm-289	35	18	iron	iron	NOUN
ajlm-289	35	19	supplements	supplement	NOUN
ajlm-289	35	20	were	be	AUX
ajlm-289	35	21	prescribed	prescribe	VERB
ajlm-289	35	22	.	.	PUNCT
ajlm-289	36	1	in	in	ADP
ajlm-289	36	2	november	november	PROPN
ajlm-289	36	3	2012	2012	NUM
ajlm-289	36	4	she	she	PRON
ajlm-289	36	5	presented	present	VERB
ajlm-289	36	6	at	at	ADP
ajlm-289	36	7	a	a	DET
ajlm-289	36	8	local	local	ADJ
ajlm-289	36	9	hospital	hospital	NOUN
ajlm-289	36	10	complaining	complaining	NOUN
ajlm-289	36	11	of	of	ADP
ajlm-289	36	12	severe	severe	ADJ
ajlm-289	36	13	back	back	ADJ
ajlm-289	36	14	pain	pain	NOUN
ajlm-289	36	15	and	and	CCONJ
ajlm-289	36	16	persistent	persistent	ADJ
ajlm-289	36	17	vaginal	vaginal	ADJ
ajlm-289	36	18	bleeding	bleeding	NOUN
ajlm-289	36	19	.	.	PUNCT
ajlm-289	37	1	her	her	PRON
ajlm-289	37	2	past	past	ADJ
ajlm-289	37	3	medical	medical	ADJ
ajlm-289	37	4	history	history	NOUN
ajlm-289	37	5	revealed	reveal	VERB
ajlm-289	37	6	that	that	SCONJ
ajlm-289	37	7	this	this	PRON
ajlm-289	37	8	had	have	AUX
ajlm-289	37	9	been	be	AUX
ajlm-289	37	10	ongoing	ongoing	ADJ
ajlm-289	37	11	for	for	ADP
ajlm-289	37	12	more	more	ADJ
ajlm-289	37	13	than	than	ADP
ajlm-289	37	14	one	one	NUM
ajlm-289	37	15	month	month	NOUN
ajlm-289	37	16	.	.	PUNCT
ajlm-289	38	1	on	on	ADP
ajlm-289	38	2	admission	admission	NOUN
ajlm-289	38	3	she	she	PRON
ajlm-289	38	4	was	be	AUX
ajlm-289	38	5	found	find	VERB
ajlm-289	38	6	to	to	PART
ajlm-289	38	7	have	have	VERB
ajlm-289	38	8	no	no	DET
ajlm-289	38	9	significant	significant	ADJ
ajlm-289	38	10	lymphadenopathy	lymphadenopathy	NOUN
ajlm-289	38	11	or	or	CCONJ
ajlm-289	38	12	hepatosplenomegaly	hepatosplenomegaly	NOUN
ajlm-289	38	13	.	.	PUNCT
ajlm-289	39	1	she	she	PRON
ajlm-289	39	2	was	be	AUX
ajlm-289	39	3	also	also	ADV
ajlm-289	39	4	tachycardic	tachycardic	ADJ
ajlm-289	39	5	and	and	CCONJ
ajlm-289	39	6	an	an	DET
ajlm-289	39	7	echocardiogram	echocardiogram	NOUN
ajlm-289	39	8	revealed	reveal	VERB
ajlm-289	39	9	a	a	DET
ajlm-289	39	10	functional	functional	ADJ
ajlm-289	39	11	ejection	ejection	NOUN
ajlm-289	39	12	systolic	systolic	NOUN
ajlm-289	39	13	murmur	murmur	NOUN
ajlm-289	39	14	.	.	PUNCT
ajlm-289	40	1	a	a	DET
ajlm-289	40	2	radiographic	radiographic	ADJ
ajlm-289	40	3	skeletal	skeletal	ADJ
ajlm-289	40	4	survey	survey	NOUN
ajlm-289	40	5	showed	show	VERB
ajlm-289	40	6	multiple	multiple	ADJ
ajlm-289	40	7	lytic	lytic	ADJ
ajlm-289	40	8	lesions	lesion	NOUN
ajlm-289	40	9	(	(	PUNCT
ajlm-289	40	10	figure	figure	NOUN
ajlm-289	40	11	1	1	NUM
ajlm-289	40	12	)	)	PUNCT
ajlm-289	40	13	.	.	PUNCT
ajlm-289	41	1	all	all	DET
ajlm-289	41	2	pertinent	pertinent	ADJ
ajlm-289	41	3	laboratory	laboratory	NOUN
ajlm-289	41	4	investigations	investigation	NOUN
ajlm-289	41	5	are	be	AUX
ajlm-289	41	6	summarised	summarise	VERB
ajlm-289	41	7	in	in	ADP
ajlm-289	41	8	table	table	NOUN
ajlm-289	41	9	1	1	NUM
ajlm-289	41	10	.	.	PUNCT
ajlm-289	42	1	figure	figure	NOUN
ajlm-289	42	2	1	1	NUM
ajlm-289	42	3	:	:	PUNCT
ajlm-289	42	4	radiographic	radiographic	ADJ
ajlm-289	42	5	skeletal	skeletal	ADJ
ajlm-289	42	6	survey	survey	NOUN
ajlm-289	42	7	showing	show	VERB
ajlm-289	42	8	multiple	multiple	ADJ
ajlm-289	42	9	lytic	lytic	ADJ
ajlm-289	42	10	lesions	lesion	NOUN
ajlm-289	42	11	although	although	SCONJ
ajlm-289	42	12	no	no	DET
ajlm-289	42	13	pathological	pathological	ADJ
ajlm-289	42	14	fractures	fracture	NOUN
ajlm-289	42	15	were	be	AUX
ajlm-289	42	16	present	present	ADJ
ajlm-289	42	17	.	.	PUNCT
ajlm-289	43	1	(	(	PUNCT
ajlm-289	43	2	a	a	X
ajlm-289	43	3	)	)	PUNCT
ajlm-289	43	4	the	the	DET
ajlm-289	43	5	lesions	lesion	NOUN
ajlm-289	43	6	involved	involve	VERB
ajlm-289	43	7	the	the	DET
ajlm-289	43	8	ribs	rib	NOUN
ajlm-289	43	9	,	,	PUNCT
ajlm-289	43	10	the	the	DET
ajlm-289	43	11	shoulders	shoulder	NOUN
ajlm-289	43	12	bilaterally	bilaterally	ADV
ajlm-289	43	13	and	and	CCONJ
ajlm-289	43	14	the	the	DET
ajlm-289	43	15	spine	spine	NOUN
ajlm-289	43	16	.	.	PUNCT
ajlm-289	44	1	(	(	PUNCT
ajlm-289	44	2	b	b	X
ajlm-289	44	3	)	)	PUNCT
ajlm-289	44	4	the	the	DET
ajlm-289	44	5	pelvis	pelvi	NOUN
ajlm-289	44	6	and	and	CCONJ
ajlm-289	44	7	the	the	DET
ajlm-289	44	8	upper	upper	ADJ
ajlm-289	44	9	femora	femora	NOUN
ajlm-289	44	10	also	also	ADV
ajlm-289	44	11	reveal	reveal	VERB
ajlm-289	44	12	lytic	lytic	ADJ
ajlm-289	44	13	lesions	lesion	NOUN
ajlm-289	44	14	.	.	PUNCT
ajlm-289	45	1	a	a	DET
ajlm-289	45	2	number	number	NOUN
ajlm-289	45	3	of	of	ADP
ajlm-289	45	4	baseline	baseline	NOUN
ajlm-289	45	5	and	and	CCONJ
ajlm-289	45	6	definitive	definitive	ADJ
ajlm-289	45	7	special	special	ADJ
ajlm-289	45	8	investigations	investigation	NOUN
ajlm-289	45	9	were	be	AUX
ajlm-289	45	10	performed	perform	VERB
ajlm-289	45	11	(	(	PUNCT
ajlm-289	45	12	table	table	NOUN
ajlm-289	45	13	1	1	NUM
ajlm-289	45	14	)	)	PUNCT
ajlm-289	45	15	.	.	PUNCT
ajlm-289	46	1	a	a	DET
ajlm-289	46	2	bone	bone	NOUN
ajlm-289	46	3	marrow	marrow	NOUN
ajlm-289	46	4	investigation	investigation	NOUN
ajlm-289	46	5	revealed	reveal	VERB
ajlm-289	46	6	hypercellular	hypercellular	ADJ
ajlm-289	46	7	marrow	marrow	NOUN
ajlm-289	46	8	with	with	ADP
ajlm-289	46	9	extensive	extensive	ADJ
ajlm-289	46	10	infiltration	infiltration	NOUN
ajlm-289	46	11	by	by	ADP
ajlm-289	46	12	a	a	DET
ajlm-289	46	13	population	population	NOUN
ajlm-289	46	14	of	of	ADP
ajlm-289	46	15	abnormal	abnormal	ADJ
ajlm-289	46	16	plasma	plasma	NOUN
ajlm-289	46	17	cells	cell	NOUN
ajlm-289	46	18	similar	similar	ADJ
ajlm-289	46	19	to	to	ADP
ajlm-289	46	20	that	that	PRON
ajlm-289	46	21	described	describe	VERB
ajlm-289	46	22	in	in	ADP
ajlm-289	46	23	the	the	DET
ajlm-289	46	24	peripheral	peripheral	ADJ
ajlm-289	46	25	blood	blood	NOUN
ajlm-289	46	26	(	(	PUNCT
ajlm-289	46	27	figure	figure	NOUN
ajlm-289	46	28	2a	2a	NUM
ajlm-289	46	29	,	,	PUNCT
ajlm-289	46	30	2b	2b	NUM
ajlm-289	46	31	and	and	CCONJ
ajlm-289	46	32	2c	2c	NUM
ajlm-289	46	33	)	)	PUNCT
ajlm-289	46	34	.	.	PUNCT
ajlm-289	47	1	the	the	DET
ajlm-289	47	2	infiltrate	infiltrate	NOUN
ajlm-289	47	3	was	be	AUX
ajlm-289	47	4	positive	positive	ADJ
ajlm-289	47	5	for	for	ADP
ajlm-289	47	6	immunohistochemical	immunohistochemical	ADJ
ajlm-289	47	7	stains	stain	NOUN
ajlm-289	47	8	,	,	PUNCT
ajlm-289	47	9	including	include	VERB
ajlm-289	47	10	cd38	cd38	PROPN
ajlm-289	47	11	(	(	PUNCT
ajlm-289	47	12	figure	figure	NOUN
ajlm-289	47	13	2d	2d	NUM
ajlm-289	47	14	)	)	PUNCT
ajlm-289	47	15	,	,	PUNCT
ajlm-289	47	16	cd56	cd56	PROPN
ajlm-289	47	17	and	and	CCONJ
ajlm-289	47	18	mum-1	mum-1	PRON
ajlm-289	47	19	,	,	PUNCT
ajlm-289	47	20	but	but	CCONJ
ajlm-289	47	21	was	be	AUX
ajlm-289	47	22	negative	negative	ADJ
ajlm-289	47	23	for	for	ADP
ajlm-289	47	24	cyclin	cyclin	NOUN
ajlm-289	47	25	-	-	PUNCT
ajlm-289	47	26	d1	d1	PROPN
ajlm-289	47	27	,	,	PUNCT
ajlm-289	47	28	cd20	cd20	PROPN
ajlm-289	47	29	and	and	CCONJ
ajlm-289	47	30	cd45	cd45	PROPN
ajlm-289	47	31	.	.	PUNCT
ajlm-289	48	1	fewer	few	ADJ
ajlm-289	48	2	than	than	ADP
ajlm-289	48	3	20	20	NUM
ajlm-289	48	4	%	%	NOUN
ajlm-289	48	5	of	of	ADP
ajlm-289	48	6	cells	cell	NOUN
ajlm-289	48	7	were	be	AUX
ajlm-289	48	8	positive	positive	ADJ
ajlm-289	48	9	for	for	ADP
ajlm-289	48	10	ki-67	ki-67	PRON
ajlm-289	48	11	.	.	PUNCT
ajlm-289	49	1	immunophenotypic	immunophenotypic	ADJ
ajlm-289	49	2	analysis	analysis	NOUN
ajlm-289	49	3	revealed	reveal	VERB
ajlm-289	49	4	a	a	DET
ajlm-289	49	5	population	population	NOUN
ajlm-289	49	6	of	of	ADP
ajlm-289	49	7	~60	~60	PRON
ajlm-289	49	8	%	%	NOUN
ajlm-289	49	9	–	–	PUNCT
ajlm-289	49	10	70	70	NUM
ajlm-289	49	11	%	%	NOUN
ajlm-289	49	12	large	large	ADJ
ajlm-289	49	13	,	,	PUNCT
ajlm-289	49	14	more	more	ADV
ajlm-289	49	15	complex	complex	ADJ
ajlm-289	49	16	cells	cell	NOUN
ajlm-289	49	17	that	that	PRON
ajlm-289	49	18	expressed	express	VERB
ajlm-289	49	19	bright	bright	ADJ
ajlm-289	49	20	cd38	cd38	PROPN
ajlm-289	49	21	,	,	PUNCT
ajlm-289	49	22	moderate	moderate	ADJ
ajlm-289	49	23	cd138	cd138	NOUN
ajlm-289	49	24	and	and	CCONJ
ajlm-289	49	25	bright	bright	ADJ
ajlm-289	49	26	aberrant	aberrant	NOUN
ajlm-289	49	27	cd56	cd56	PROPN
ajlm-289	49	28	with	with	ADP
ajlm-289	49	29	dim	dim	ADJ
ajlm-289	49	30	kappa	kappa	ADJ
ajlm-289	49	31	light	light	NOUN
ajlm-289	49	32	-	-	PUNCT
ajlm-289	49	33	chain	chain	NOUN
ajlm-289	49	34	restriction	restriction	NOUN
ajlm-289	49	35	.	.	PUNCT
ajlm-289	50	1	figure	figure	NOUN
ajlm-289	50	2	2	2	NUM
ajlm-289	50	3	:	:	PUNCT
ajlm-289	50	4	bone	bone	NOUN
ajlm-289	50	5	marrow	marrow	NOUN
ajlm-289	50	6	aspirate	aspirate	NOUN
ajlm-289	50	7	and	and	CCONJ
ajlm-289	50	8	trephine	trephine	NOUN
ajlm-289	50	9	samples	sample	NOUN
ajlm-289	50	10	of	of	ADP
ajlm-289	50	11	primary	primary	ADJ
ajlm-289	50	12	plasma	plasma	NOUN
ajlm-289	50	13	cell	cell	NOUN
ajlm-289	50	14	leukaemia	leukaemia	NOUN
ajlm-289	50	15	.	.	PUNCT
ajlm-289	51	1	(	(	PUNCT
ajlm-289	51	2	a	a	X
ajlm-289	51	3	)	)	PUNCT
ajlm-289	51	4	tumour	tumour	NOUN
ajlm-289	51	5	cells	cell	NOUN
ajlm-289	51	6	were	be	AUX
ajlm-289	51	7	variable	variable	ADJ
ajlm-289	51	8	in	in	ADP
ajlm-289	51	9	size	size	NOUN
ajlm-289	51	10	,	,	PUNCT
ajlm-289	51	11	ranging	range	VERB
ajlm-289	51	12	from	from	ADP
ajlm-289	51	13	small	small	ADJ
ajlm-289	51	14	to	to	PART
ajlm-289	51	15	intermediate	intermediate	VERB
ajlm-289	51	16	.	.	PUNCT
ajlm-289	52	1	the	the	DET
ajlm-289	52	2	nuclei	nucleus	NOUN
ajlm-289	52	3	were	be	AUX
ajlm-289	52	4	rounded	rounded	ADJ
ajlm-289	52	5	and	and	CCONJ
ajlm-289	52	6	eccentric	eccentric	ADJ
ajlm-289	52	7	and	and	CCONJ
ajlm-289	52	8	a	a	DET
ajlm-289	52	9	peri	peri	NOUN
ajlm-289	52	10	-	-	PUNCT
ajlm-289	52	11	nuclear	nuclear	ADJ
ajlm-289	52	12	hoff	hoff	NOUN
ajlm-289	52	13	was	be	AUX
ajlm-289	52	14	also	also	ADV
ajlm-289	52	15	noted	note	VERB
ajlm-289	52	16	(	(	PUNCT
ajlm-289	52	17	giemsa	giemsa	ADJ
ajlm-289	52	18	staining	staining	NOUN
ajlm-289	52	19	.	.	PUNCT
ajlm-289	53	1	magnification	magnification	NOUN
ajlm-289	53	2	:	:	PUNCT
ajlm-289	53	3	50×	50×	NUM
ajlm-289	53	4	)	)	PUNCT
ajlm-289	53	5	.	.	PUNCT
ajlm-289	54	1	(	(	PUNCT
ajlm-289	54	2	b	b	X
ajlm-289	54	3	)	)	PUNCT
ajlm-289	54	4	occasional	occasional	ADJ
ajlm-289	54	5	,	,	PUNCT
ajlm-289	54	6	more	more	ADV
ajlm-289	54	7	primitive	primitive	ADJ
ajlm-289	54	8	binucleate	binucleate	NOUN
ajlm-289	54	9	forms	form	NOUN
ajlm-289	54	10	were	be	AUX
ajlm-289	54	11	also	also	ADV
ajlm-289	54	12	observed	observe	VERB
ajlm-289	54	13	(	(	PUNCT
ajlm-289	54	14	giemsa	giemsa	ADJ
ajlm-289	54	15	staining	staining	NOUN
ajlm-289	54	16	.	.	PUNCT
ajlm-289	55	1	magnification	magnification	NOUN
ajlm-289	55	2	:	:	PUNCT
ajlm-289	55	3	50×	50×	NUM
ajlm-289	55	4	)	)	PUNCT
ajlm-289	55	5	.	.	PUNCT
ajlm-289	56	1	(	(	PUNCT
ajlm-289	56	2	c	c	X
ajlm-289	56	3	)	)	PUNCT
ajlm-289	56	4	the	the	DET
ajlm-289	56	5	chromatin	chromatin	NOUN
ajlm-289	56	6	appeared	appear	VERB
ajlm-289	56	7	clumped	clump	VERB
ajlm-289	56	8	but	but	CCONJ
ajlm-289	56	9	had	have	VERB
ajlm-289	56	10	a	a	DET
ajlm-289	56	11	more	more	ADV
ajlm-289	56	12	primitive	primitive	ADJ
ajlm-289	56	13	appearance	appearance	NOUN
ajlm-289	56	14	in	in	ADP
ajlm-289	56	15	the	the	DET
ajlm-289	56	16	larger	large	ADJ
ajlm-289	56	17	cells	cell	NOUN
ajlm-289	56	18	with	with	ADP
ajlm-289	56	19	occasional	occasional	ADJ
ajlm-289	56	20	nucleoli	nucleolus	NOUN
ajlm-289	56	21	(	(	PUNCT
ajlm-289	56	22	giemsa	giemsa	ADJ
ajlm-289	56	23	staining	staining	NOUN
ajlm-289	56	24	.	.	PUNCT
ajlm-289	57	1	magnification	magnification	NOUN
ajlm-289	57	2	:	:	PUNCT
ajlm-289	57	3	50×	50×	NUM
ajlm-289	57	4	)	)	PUNCT
ajlm-289	57	5	.	.	PUNCT
ajlm-289	58	1	(	(	PUNCT
ajlm-289	58	2	d	d	X
ajlm-289	58	3	)	)	PUNCT
ajlm-289	58	4	normal	normal	ADJ
ajlm-289	58	5	haemopoiesis	haemopoiesis	NOUN
ajlm-289	58	6	was	be	AUX
ajlm-289	58	7	mostly	mostly	ADV
ajlm-289	58	8	displaced	displace	VERB
ajlm-289	58	9	by	by	ADP
ajlm-289	58	10	the	the	DET
ajlm-289	58	11	extensive	extensive	ADJ
ajlm-289	58	12	diffuse	diffuse	NOUN
ajlm-289	58	13	infiltrate	infiltrate	NOUN
ajlm-289	58	14	of	of	ADP
ajlm-289	58	15	cd38	cd38	PROPN
ajlm-289	58	16	positive	positive	ADJ
ajlm-289	58	17	cells	cell	NOUN
ajlm-289	58	18	(	(	PUNCT
ajlm-289	58	19	anti	anti	ADJ
ajlm-289	58	20	-	-	ADJ
ajlm-289	58	21	cd38	cd38	NOUN
ajlm-289	58	22	staining	stain	VERB
ajlm-289	58	23	.	.	PUNCT
ajlm-289	59	1	magnification	magnification	NOUN
ajlm-289	59	2	:	:	PUNCT
ajlm-289	59	3	40×	40×	NOUN
ajlm-289	59	4	)	)	PUNCT
ajlm-289	59	5	.	.	PUNCT
ajlm-289	60	1	fluorescence	fluorescence	NOUN
ajlm-289	60	2	in	in	ADP
ajlm-289	60	3	situ	situ	ADJ
ajlm-289	60	4	hybridisation	hybridisation	NOUN
ajlm-289	60	5	analysis	analysis	NOUN
ajlm-289	60	6	revealed	reveal	VERB
ajlm-289	60	7	that	that	SCONJ
ajlm-289	60	8	the	the	DET
ajlm-289	60	9	cells	cell	NOUN
ajlm-289	60	10	were	be	AUX
ajlm-289	60	11	positive	positive	ADJ
ajlm-289	60	12	for	for	ADP
ajlm-289	60	13	a	a	DET
ajlm-289	60	14	deletion	deletion	NOUN
ajlm-289	60	15	at	at	ADP
ajlm-289	60	16	13q14.3	13q14.3	NUM
ajlm-289	60	17	,	,	PUNCT
ajlm-289	60	18	showed	show	VERB
ajlm-289	60	19	trisomy	trisomy	NOUN
ajlm-289	60	20	of	of	ADP
ajlm-289	60	21	chromosome	chromosome	NOUN
ajlm-289	60	22	18	18	NUM
ajlm-289	60	23	and	and	CCONJ
ajlm-289	60	24	loss	loss	NOUN
ajlm-289	60	25	of	of	ADP
ajlm-289	60	26	the	the	DET
ajlm-289	60	27	fibroblast	fibroblast	ADJ
ajlm-289	60	28	growth	growth	NOUN
ajlm-289	60	29	factor	factor	NOUN
ajlm-289	60	30	receptor	receptor	NOUN
ajlm-289	60	31	(	(	PUNCT
ajlm-289	60	32	fgfr3	fgfr3	NOUN
ajlm-289	60	33	)	)	PUNCT
ajlm-289	60	34	gene	gene	NOUN
ajlm-289	60	35	.	.	PUNCT
ajlm-289	61	1	chromosomal	chromosomal	ADJ
ajlm-289	61	2	analysis	analysis	NOUN
ajlm-289	61	3	of	of	ADP
ajlm-289	61	4	the	the	DET
ajlm-289	61	5	bone	bone	NOUN
ajlm-289	61	6	marrow	marrow	NOUN
ajlm-289	61	7	cultures	culture	NOUN
ajlm-289	61	8	revealed	reveal	VERB
ajlm-289	61	9	a	a	DET
ajlm-289	61	10	complex	complex	ADJ
ajlm-289	61	11	karyotype	karyotype	NOUN
ajlm-289	61	12	(	(	PUNCT
ajlm-289	61	13	table	table	NOUN
ajlm-289	61	14	1	1	NUM
ajlm-289	61	15	)	)	PUNCT
ajlm-289	61	16	.	.	PUNCT
ajlm-289	62	1	features	feature	NOUN
ajlm-289	62	2	of	of	ADP
ajlm-289	62	3	note	note	NOUN
ajlm-289	62	4	were	be	AUX
ajlm-289	62	5	numerical	numerical	ADJ
ajlm-289	62	6	aberrations	aberration	NOUN
ajlm-289	62	7	,	,	PUNCT
ajlm-289	62	8	including	include	VERB
ajlm-289	62	9	monosomy	monosomy	NOUN
ajlm-289	62	10	of	of	ADP
ajlm-289	62	11	chromosomes	chromosome	NOUN
ajlm-289	62	12	12	12	NUM
ajlm-289	62	13	,	,	PUNCT
ajlm-289	62	14	13	13	NUM
ajlm-289	62	15	and	and	CCONJ
ajlm-289	62	16	14	14	NUM
ajlm-289	62	17	and	and	CCONJ
ajlm-289	62	18	trisomy	trisomy	NOUN
ajlm-289	62	19	of	of	ADP
ajlm-289	62	20	chromosome	chromosome	NOUN
ajlm-289	62	21	18	18	NUM
ajlm-289	62	22	.	.	PUNCT
ajlm-289	63	1	structural	structural	ADJ
ajlm-289	63	2	aberrations	aberration	NOUN
ajlm-289	63	3	included	include	VERB
ajlm-289	63	4	partial	partial	ADJ
ajlm-289	63	5	deletion	deletion	NOUN
ajlm-289	63	6	of	of	ADP
ajlm-289	63	7	chromosome	chromosome	NOUN
ajlm-289	63	8	1p	1p	NUM
ajlm-289	63	9	and	and	CCONJ
ajlm-289	63	10	an	an	DET
ajlm-289	63	11	extra	extra	ADJ
ajlm-289	63	12	chromosome	chromosome	NOUN
ajlm-289	63	13	1	1	NUM
ajlm-289	63	14	with	with	ADP
ajlm-289	63	15	a	a	DET
ajlm-289	63	16	partial	partial	ADJ
ajlm-289	63	17	deletion	deletion	NOUN
ajlm-289	63	18	on	on	ADP
ajlm-289	63	19	the	the	DET
ajlm-289	63	20	p	p	NOUN
ajlm-289	63	21	-	-	PUNCT
ajlm-289	63	22	arm	arm	NOUN
ajlm-289	63	23	,	,	PUNCT
ajlm-289	63	24	leading	lead	VERB
ajlm-289	63	25	to	to	ADP
ajlm-289	63	26	an	an	DET
ajlm-289	63	27	additional	additional	ADJ
ajlm-289	63	28	copy	copy	NOUN
ajlm-289	63	29	of	of	ADP
ajlm-289	63	30	the	the	DET
ajlm-289	63	31	1q	1q	NUM
ajlm-289	63	32	region	region	NOUN
ajlm-289	63	33	.	.	PUNCT
ajlm-289	64	1	there	there	PRON
ajlm-289	64	2	was	be	VERB
ajlm-289	64	3	a	a	DET
ajlm-289	64	4	translocation	translocation	NOUN
ajlm-289	64	5	involving	involve	VERB
ajlm-289	64	6	chromosomes	chromosome	NOUN
ajlm-289	64	7	3	3	NUM
ajlm-289	64	8	and	and	CCONJ
ajlm-289	64	9	14	14	NUM
ajlm-289	64	10	,	,	PUNCT
ajlm-289	64	11	leading	lead	VERB
ajlm-289	64	12	to	to	ADP
ajlm-289	64	13	rearrangement	rearrangement	NOUN
ajlm-289	64	14	of	of	ADP
ajlm-289	64	15	the	the	DET
ajlm-289	64	16	immunoglobulin	immunoglobulin	NOUN
ajlm-289	64	17	heavy	heavy	ADJ
ajlm-289	64	18	chain	chain	NOUN
ajlm-289	64	19	locus	locus	NOUN
ajlm-289	64	20	(	(	PUNCT
ajlm-289	64	21	igh@	igh@	PROPN
ajlm-289	64	22	)	)	PUNCT
ajlm-289	64	23	gene	gene	NOUN
ajlm-289	64	24	.	.	PUNCT
ajlm-289	65	1	terminal	terminal	ADJ
ajlm-289	65	2	deletion	deletion	NOUN
ajlm-289	65	3	of	of	ADP
ajlm-289	65	4	chromosome	chromosome	NOUN
ajlm-289	65	5	4p	4p	NOUN
ajlm-289	65	6	confirmed	confirm	VERB
ajlm-289	65	7	the	the	DET
ajlm-289	65	8	deletion	deletion	NOUN
ajlm-289	65	9	of	of	ADP
ajlm-289	65	10	the	the	DET
ajlm-289	65	11	fgfr3	fgfr3	NOUN
ajlm-289	65	12	gene	gene	NOUN
ajlm-289	65	13	.	.	PUNCT
ajlm-289	66	1	table	table	NOUN
ajlm-289	66	2	1	1	NUM
ajlm-289	66	3	:	:	PUNCT
ajlm-289	66	4	 	 	SPACE
ajlm-289	66	5	summary	summary	NOUN
ajlm-289	66	6	of	of	ADP
ajlm-289	66	7	relevant	relevant	ADJ
ajlm-289	66	8	laboratory	laboratory	NOUN
ajlm-289	66	9	investigations	investigation	NOUN
ajlm-289	66	10	performed	perform	VERB
ajlm-289	66	11	on	on	ADP
ajlm-289	66	12	this	this	DET
ajlm-289	66	13	patient	patient	NOUN
ajlm-289	66	14	.	.	PUNCT
ajlm-289	67	1	management	management	NOUN
ajlm-289	67	2	and	and	CCONJ
ajlm-289	67	3	outcome	outcome	VERB
ajlm-289	67	4	top	top	ADJ
ajlm-289	67	5	↑	↑	PROPN
ajlm-289	67	6	on	on	ADP
ajlm-289	67	7	admission	admission	NOUN
ajlm-289	67	8	,	,	PUNCT
ajlm-289	67	9	the	the	DET
ajlm-289	67	10	patient	patient	NOUN
ajlm-289	67	11	was	be	AUX
ajlm-289	67	12	stabilised	stabilise	VERB
ajlm-289	67	13	and	and	CCONJ
ajlm-289	67	14	given	give	VERB
ajlm-289	67	15	fresh	fresh	ADJ
ajlm-289	67	16	frozen	frozen	ADJ
ajlm-289	67	17	plasma	plasma	NOUN
ajlm-289	67	18	,	,	PUNCT
ajlm-289	67	19	platelets	platelet	NOUN
ajlm-289	67	20	and	and	CCONJ
ajlm-289	67	21	packed	packed	ADJ
ajlm-289	67	22	cells	cell	NOUN
ajlm-289	67	23	.	.	PUNCT
ajlm-289	68	1	with	with	ADP
ajlm-289	68	2	confirmation	confirmation	NOUN
ajlm-289	68	3	of	of	ADP
ajlm-289	68	4	the	the	DET
ajlm-289	68	5	diagnosis	diagnosis	NOUN
ajlm-289	68	6	,	,	PUNCT
ajlm-289	68	7	the	the	DET
ajlm-289	68	8	patient	patient	NOUN
ajlm-289	68	9	was	be	AUX
ajlm-289	68	10	started	start	VERB
ajlm-289	68	11	on	on	ADP
ajlm-289	68	12	a	a	DET
ajlm-289	68	13	chemotherapy	chemotherapy	NOUN
ajlm-289	68	14	regimen	regiman	NOUN
ajlm-289	68	15	which	which	PRON
ajlm-289	68	16	included	include	VERB
ajlm-289	68	17	:	:	PUNCT
ajlm-289	68	18	vincristine	vincristine	NOUN
ajlm-289	68	19	3.6	3.6	NUM
ajlm-289	68	20	 	 	SPACE
ajlm-289	68	21	mg	mg	PROPN
ajlm-289	68	22	/	/	SYM
ajlm-289	68	23	m2	m2	PROPN
ajlm-289	68	24	intravenously	intravenously	ADV
ajlm-289	68	25	on	on	ADP
ajlm-289	68	26	days	day	NOUN
ajlm-289	68	27	1–4	1–4	PROPN
ajlm-289	68	28	(	(	PUNCT
ajlm-289	68	29	d1	d1	PROPN
ajlm-289	68	30	–	–	PUNCT
ajlm-289	68	31	d4	d4	PROPN
ajlm-289	68	32	)	)	PUNCT
ajlm-289	68	33	,	,	PUNCT
ajlm-289	68	34	doxorubicin	doxorubicin	PROPN
ajlm-289	68	35	9	9	NUM
ajlm-289	68	36	 	 	SPACE
ajlm-289	68	37	mg	mg	PROPN
ajlm-289	68	38	/	/	SYM
ajlm-289	68	39	m2	m2	PROPN
ajlm-289	68	40	intravenously	intravenously	ADV
ajlm-289	68	41	on	on	ADP
ajlm-289	68	42	d1	d1	PROPN
ajlm-289	68	43	–	–	PUNCT
ajlm-289	68	44	d4	d4	PROPN
ajlm-289	68	45	,	,	PUNCT
ajlm-289	68	46	dexamethasone	dexamethasone	NOUN
ajlm-289	68	47	40	40	NUM
ajlm-289	68	48	 	 	SPACE
ajlm-289	68	49	mg	mg	PROPN
ajlm-289	68	50	orally	orally	ADV
ajlm-289	68	51	on	on	ADP
ajlm-289	68	52	d1	d1	PROPN
ajlm-289	68	53	–	–	PUNCT
ajlm-289	68	54	d4	d4	PROPN
ajlm-289	68	55	,	,	PUNCT
ajlm-289	68	56	dexamethasone	dexamethasone	NOUN
ajlm-289	68	57	40	40	NUM
ajlm-289	68	58	 	 	SPACE
ajlm-289	68	59	mg	mg	PROPN
ajlm-289	68	60	orally	orally	ADV
ajlm-289	68	61	on	on	ADP
ajlm-289	68	62	d9	d9	PROPN
ajlm-289	68	63	–	–	PUNCT
ajlm-289	68	64	d12	d12	NUM
ajlm-289	68	65	,	,	PUNCT
ajlm-289	68	66	dexamethasone	dexamethasone	NOUN
ajlm-289	68	67	40	40	NUM
ajlm-289	68	68	 	 	SPACE
ajlm-289	68	69	mg	mg	PROPN
ajlm-289	68	70	orally	orally	ADV
ajlm-289	68	71	on	on	ADP
ajlm-289	68	72	d17	d17	NOUN
ajlm-289	68	73	–	–	PUNCT
ajlm-289	68	74	d20	d20	ADJ
ajlm-289	68	75	.	.	PUNCT
ajlm-289	69	1	she	she	PRON
ajlm-289	69	2	received	receive	VERB
ajlm-289	69	3	one	one	NUM
ajlm-289	69	4	cycle	cycle	NOUN
ajlm-289	69	5	of	of	ADP
ajlm-289	69	6	therapy	therapy	NOUN
ajlm-289	69	7	;	;	PUNCT
ajlm-289	69	8	however	however	ADV
ajlm-289	69	9	,	,	PUNCT
ajlm-289	69	10	this	this	DET
ajlm-289	69	11	induction	induction	NOUN
ajlm-289	69	12	failed	fail	VERB
ajlm-289	69	13	to	to	PART
ajlm-289	69	14	induce	induce	VERB
ajlm-289	69	15	remission	remission	NOUN
ajlm-289	69	16	.	.	PUNCT
ajlm-289	70	1	discussion	discussion	NOUN
ajlm-289	70	2	top	top	PROPN
ajlm-289	70	3	↑	↑	PROPN
ajlm-289	70	4	de	de	PROPN
ajlm-289	70	5	novo	novo	PROPN
ajlm-289	70	6	pcl	pcl	PROPN
ajlm-289	70	7	is	be	AUX
ajlm-289	70	8	a	a	DET
ajlm-289	70	9	rare	rare	ADJ
ajlm-289	70	10	disease	disease	NOUN
ajlm-289	70	11	and	and	CCONJ
ajlm-289	70	12	presentation	presentation	NOUN
ajlm-289	70	13	in	in	ADP
ajlm-289	70	14	patients	patient	NOUN
ajlm-289	70	15	aged	age	VERB
ajlm-289	70	16	younger	young	ADJ
ajlm-289	70	17	than	than	ADP
ajlm-289	70	18	40	40	NUM
ajlm-289	70	19	years	year	NOUN
ajlm-289	70	20	is	be	AUX
ajlm-289	70	21	exceptionally	exceptionally	ADV
ajlm-289	70	22	rare	rare	ADJ
ajlm-289	70	23	.	.	PUNCT
ajlm-289	71	1	to	to	ADP
ajlm-289	71	2	the	the	DET
ajlm-289	71	3	best	good	ADJ
ajlm-289	71	4	of	of	ADP
ajlm-289	71	5	our	our	PRON
ajlm-289	71	6	knowledge	knowledge	NOUN
ajlm-289	71	7	,	,	PUNCT
ajlm-289	71	8	only	only	ADV
ajlm-289	71	9	two	two	NUM
ajlm-289	71	10	case	case	NOUN
ajlm-289	71	11	reports	report	NOUN
ajlm-289	71	12	of	of	ADP
ajlm-289	71	13	such	such	ADJ
ajlm-289	71	14	patients	patient	NOUN
ajlm-289	71	15	,	,	PUNCT
ajlm-289	71	16	in	in	ADP
ajlm-289	71	17	whom	whom	PRON
ajlm-289	71	18	primary	primary	ADJ
ajlm-289	71	19	pcl	pcl	PROPN
ajlm-289	71	20	presented	present	VERB
ajlm-289	71	21	at	at	ADP
ajlm-289	71	22	aged	aged	ADJ
ajlm-289	71	23	30	30	NUM
ajlm-289	71	24	and	and	CCONJ
ajlm-289	71	25	21	21	NUM
ajlm-289	71	26	years	year	NOUN
ajlm-289	71	27	,	,	PUNCT
ajlm-289	71	28	have	have	AUX
ajlm-289	71	29	been	be	AUX
ajlm-289	71	30	reported	report	VERB
ajlm-289	71	31	in	in	ADP
ajlm-289	71	32	the	the	DET
ajlm-289	71	33	literature.8,9	literature.8,9	PROPN
ajlm-289	71	34	as	as	SCONJ
ajlm-289	71	35	is	be	AUX
ajlm-289	71	36	often	often	ADV
ajlm-289	71	37	reported	report	VERB
ajlm-289	71	38	,	,	PUNCT
ajlm-289	71	39	this	this	DET
ajlm-289	71	40	patient	patient	NOUN
ajlm-289	71	41	presented	present	VERB
ajlm-289	71	42	with	with	ADP
ajlm-289	71	43	symptoms	symptom	NOUN
ajlm-289	71	44	suggestive	suggestive	ADJ
ajlm-289	71	45	of	of	ADP
ajlm-289	71	46	an	an	DET
ajlm-289	71	47	acute	acute	ADJ
ajlm-289	71	48	leukaemia	leukaemia	NOUN
ajlm-289	71	49	.	.	PUNCT
ajlm-289	72	1	however	however	ADV
ajlm-289	72	2	,	,	PUNCT
ajlm-289	72	3	some	some	PRON
ajlm-289	72	4	of	of	ADP
ajlm-289	72	5	her	her	PRON
ajlm-289	72	6	presenting	present	VERB
ajlm-289	72	7	symptoms	symptom	NOUN
ajlm-289	72	8	would	would	AUX
ajlm-289	72	9	more	more	ADV
ajlm-289	72	10	commonly	commonly	ADV
ajlm-289	72	11	be	be	AUX
ajlm-289	72	12	seen	see	VERB
ajlm-289	72	13	in	in	ADP
ajlm-289	72	14	secondary	secondary	PROPN
ajlm-289	72	15	pcl	pcl	PROPN
ajlm-289	72	16	and	and	CCONJ
ajlm-289	72	17	mm	mm	PROPN
ajlm-289	72	18	,	,	PUNCT
ajlm-289	72	19	including	include	VERB
ajlm-289	72	20	the	the	DET
ajlm-289	72	21	presence	presence	NOUN
ajlm-289	72	22	of	of	ADP
ajlm-289	72	23	bone	bone	NOUN
ajlm-289	72	24	pain	pain	NOUN
ajlm-289	72	25	and	and	CCONJ
ajlm-289	72	26	lytic	lytic	ADJ
ajlm-289	72	27	lesions	lesion	NOUN
ajlm-289	72	28	.	.	PUNCT
ajlm-289	73	1	there	there	PRON
ajlm-289	73	2	was	be	VERB
ajlm-289	73	3	no	no	DET
ajlm-289	73	4	evidence	evidence	NOUN
ajlm-289	73	5	of	of	ADP
ajlm-289	73	6	extra	extra	ADJ
ajlm-289	73	7	-	-	ADJ
ajlm-289	73	8	medullary	medullary	ADJ
ajlm-289	73	9	deposits	deposit	NOUN
ajlm-289	73	10	and	and	CCONJ
ajlm-289	73	11	there	there	PRON
ajlm-289	73	12	was	be	VERB
ajlm-289	73	13	an	an	DET
ajlm-289	73	14	absence	absence	NOUN
ajlm-289	73	15	of	of	ADP
ajlm-289	73	16	hepatomegaly	hepatomegaly	NOUN
ajlm-289	73	17	,	,	PUNCT
ajlm-289	73	18	splenomegaly	splenomegaly	ADJ
ajlm-289	73	19	and	and	CCONJ
ajlm-289	73	20	lymphadenopathy	lymphadenopathy	ADJ
ajlm-289	73	21	.	.	PUNCT
ajlm-289	74	1	there	there	PRON
ajlm-289	74	2	was	be	VERB
ajlm-289	74	3	no	no	DET
ajlm-289	74	4	evidence	evidence	NOUN
ajlm-289	74	5	of	of	ADP
ajlm-289	74	6	a	a	DET
ajlm-289	74	7	pleural	pleural	ADJ
ajlm-289	74	8	effusion	effusion	NOUN
ajlm-289	74	9	and	and	CCONJ
ajlm-289	74	10	no	no	DET
ajlm-289	74	11	renal	renal	ADJ
ajlm-289	74	12	dysfunction	dysfunction	NOUN
ajlm-289	74	13	,	,	PUNCT
ajlm-289	74	14	which	which	PRON
ajlm-289	74	15	are	be	AUX
ajlm-289	74	16	commonly	commonly	ADV
ajlm-289	74	17	described	describe	VERB
ajlm-289	74	18	in	in	ADP
ajlm-289	74	19	primary	primary	ADJ
ajlm-289	74	20	pcl.5,7,10,11	pcl.5,7,10,11	PROPN
ajlm-289	74	21	in	in	ADP
ajlm-289	74	22	addition	addition	NOUN
ajlm-289	74	23	to	to	ADP
ajlm-289	74	24	some	some	PRON
ajlm-289	74	25	of	of	ADP
ajlm-289	74	26	the	the	DET
ajlm-289	74	27	unusual	unusual	ADJ
ajlm-289	74	28	clinical	clinical	ADJ
ajlm-289	74	29	features	feature	NOUN
ajlm-289	74	30	noted	note	VERB
ajlm-289	74	31	,	,	PUNCT
ajlm-289	74	32	atypical	atypical	ADJ
ajlm-289	74	33	laboratory	laboratory	NOUN
ajlm-289	74	34	features	feature	NOUN
ajlm-289	74	35	were	be	AUX
ajlm-289	74	36	also	also	ADV
ajlm-289	74	37	found	find	VERB
ajlm-289	74	38	,	,	PUNCT
ajlm-289	74	39	including	include	VERB
ajlm-289	74	40	the	the	DET
ajlm-289	74	41	presence	presence	NOUN
ajlm-289	74	42	of	of	ADP
ajlm-289	74	43	bright	bright	ADJ
ajlm-289	74	44	cd56	cd56	PROPN
ajlm-289	74	45	expression	expression	NOUN
ajlm-289	74	46	on	on	ADP
ajlm-289	74	47	flow	flow	NOUN
ajlm-289	74	48	cytometric	cytometric	ADJ
ajlm-289	74	49	assessment	assessment	NOUN
ajlm-289	74	50	and	and	CCONJ
ajlm-289	74	51	the	the	DET
ajlm-289	74	52	absence	absence	NOUN
ajlm-289	74	53	of	of	ADP
ajlm-289	74	54	cd20	cd20	PROPN
ajlm-289	74	55	on	on	ADP
ajlm-289	74	56	immunohistochemical	immunohistochemical	ADJ
ajlm-289	74	57	staining.10	staining.10	ADJ
ajlm-289	74	58	cytogenetic	cytogenetic	ADJ
ajlm-289	74	59	abnormalities	abnormality	NOUN
ajlm-289	74	60	are	be	AUX
ajlm-289	74	61	a	a	DET
ajlm-289	74	62	common	common	ADJ
ajlm-289	74	63	feature	feature	NOUN
ajlm-289	74	64	of	of	ADP
ajlm-289	74	65	pcl	pcl	PROPN
ajlm-289	74	66	,	,	PUNCT
ajlm-289	74	67	with	with	ADP
ajlm-289	74	68	70	70	NUM
ajlm-289	74	69	%	%	NOUN
ajlm-289	74	70	of	of	ADP
ajlm-289	74	71	patients	patient	NOUN
ajlm-289	74	72	with	with	ADP
ajlm-289	74	73	primary	primary	ADJ
ajlm-289	74	74	pcl	pcl	PROPN
ajlm-289	74	75	and	and	CCONJ
ajlm-289	74	76	100	100	NUM
ajlm-289	74	77	%	%	NOUN
ajlm-289	74	78	of	of	ADP
ajlm-289	74	79	patients	patient	NOUN
ajlm-289	74	80	with	with	ADP
ajlm-289	74	81	secondary	secondary	ADJ
ajlm-289	74	82	pcl	pcl	PROPN
ajlm-289	74	83	presenting	present	VERB
ajlm-289	74	84	with	with	ADP
ajlm-289	74	85	abnormal	abnormal	ADJ
ajlm-289	74	86	karyotypes.5	karyotypes.5	PROPN
ajlm-289	75	1	a	a	DET
ajlm-289	75	2	recent	recent	ADJ
ajlm-289	75	3	study	study	NOUN
ajlm-289	75	4	that	that	PRON
ajlm-289	75	5	provided	provide	VERB
ajlm-289	75	6	a	a	DET
ajlm-289	75	7	genomic	genomic	ADJ
ajlm-289	75	8	characterisation	characterisation	NOUN
ajlm-289	75	9	of	of	ADP
ajlm-289	75	10	patients	patient	NOUN
ajlm-289	75	11	with	with	ADP
ajlm-289	75	12	primary	primary	ADJ
ajlm-289	75	13	pcl	pcl	PROPN
ajlm-289	75	14	revealed	reveal	VERB
ajlm-289	75	15	a	a	DET
ajlm-289	75	16	significant	significant	ADJ
ajlm-289	75	17	overlap	overlap	NOUN
ajlm-289	75	18	with	with	ADP
ajlm-289	75	19	characteristics	characteristic	NOUN
ajlm-289	75	20	seen	see	VERB
ajlm-289	75	21	in	in	ADP
ajlm-289	75	22	mm	mm	PROPN
ajlm-289	75	23	,	,	PUNCT
ajlm-289	75	24	although	although	SCONJ
ajlm-289	75	25	tp53	tp53	PROPN
ajlm-289	75	26	deletions	deletion	NOUN
ajlm-289	75	27	,	,	PUNCT
ajlm-289	75	28	complex	complex	ADJ
ajlm-289	75	29	karyotypes	karyotype	NOUN
ajlm-289	75	30	,	,	PUNCT
ajlm-289	75	31	hypodiploidy	hypodiploidy	ADJ
ajlm-289	75	32	and	and	CCONJ
ajlm-289	75	33	igh@	igh@	PROPN
ajlm-289	75	34	translocations	translocation	NOUN
ajlm-289	75	35	were	be	AUX
ajlm-289	75	36	more	more	ADV
ajlm-289	75	37	frequently	frequently	ADV
ajlm-289	75	38	present	present	ADJ
ajlm-289	75	39	in	in	ADP
ajlm-289	75	40	pcl.4,12,13	pcl.4,12,13	NOUN
ajlm-289	75	41	these	these	DET
ajlm-289	75	42	igh@	igh@	NOUN
ajlm-289	75	43	translocations	translocation	NOUN
ajlm-289	75	44	were	be	AUX
ajlm-289	75	45	identified	identify	VERB
ajlm-289	75	46	in	in	ADP
ajlm-289	75	47	87	87	NUM
ajlm-289	75	48	%	%	NOUN
ajlm-289	75	49	of	of	ADP
ajlm-289	75	50	primary	primary	ADJ
ajlm-289	75	51	pcl	pcl	PROPN
ajlm-289	75	52	cases	case	NOUN
ajlm-289	75	53	,	,	PUNCT
ajlm-289	75	54	del(13q	del(13q	PROPN
ajlm-289	75	55	)	)	PUNCT
ajlm-289	75	56	in	in	ADP
ajlm-289	75	57	74	74	NUM
ajlm-289	75	58	%	%	NOUN
ajlm-289	75	59	of	of	ADP
ajlm-289	75	60	cases	case	NOUN
ajlm-289	75	61	and	and	CCONJ
ajlm-289	75	62	del(17p	del(17p	NOUN
ajlm-289	75	63	)	)	PUNCT
ajlm-289	75	64	in	in	ADP
ajlm-289	75	65	35	35	NUM
ajlm-289	75	66	%	%	NOUN
ajlm-289	75	67	of	of	ADP
ajlm-289	75	68	cases.4	cases.4	PROPN
ajlm-289	75	69	in	in	ADP
ajlm-289	75	70	addition	addition	NOUN
ajlm-289	75	71	,	,	PUNCT
ajlm-289	75	72	abnormalities	abnormality	NOUN
ajlm-289	75	73	in	in	ADP
ajlm-289	75	74	chromosome	chromosome	NOUN
ajlm-289	75	75	1	1	NUM
ajlm-289	75	76	are	be	AUX
ajlm-289	75	77	frequent	frequent	ADJ
ajlm-289	75	78	in	in	ADP
ajlm-289	75	79	pcl	pcl	PROPN
ajlm-289	75	80	,	,	PUNCT
ajlm-289	75	81	particularly	particularly	ADV
ajlm-289	75	82	1q21	1q21	NUM
ajlm-289	75	83	amplification	amplification	NOUN
ajlm-289	75	84	and	and	CCONJ
ajlm-289	75	85	del(1p	del(1p	NOUN
ajlm-289	75	86	)	)	PUNCT
ajlm-289	75	87	,	,	PUNCT
ajlm-289	75	88	a	a	DET
ajlm-289	75	89	deletion	deletion	NOUN
ajlm-289	75	90	that	that	PRON
ajlm-289	75	91	has	have	AUX
ajlm-289	75	92	been	be	AUX
ajlm-289	75	93	associated	associate	VERB
ajlm-289	75	94	with	with	ADP
ajlm-289	75	95	shorter	short	ADJ
ajlm-289	75	96	overall	overall	ADJ
ajlm-289	75	97	survival.14,15	survival.14,15	NOUN
ajlm-289	75	98	both	both	PRON
ajlm-289	75	99	monosomy	monosomy	NOUN
ajlm-289	75	100	13	13	NUM
ajlm-289	75	101	and	and	CCONJ
ajlm-289	75	102	trisomy	trisomy	NOUN
ajlm-289	75	103	18	18	NUM
ajlm-289	75	104	are	be	AUX
ajlm-289	75	105	common	common	ADJ
ajlm-289	75	106	in	in	ADP
ajlm-289	75	107	pcl	pcl	PROPN
ajlm-289	75	108	,	,	PUNCT
ajlm-289	75	109	with	with	ADP
ajlm-289	75	110	monosomy	monosomy	NOUN
ajlm-289	75	111	13	13	NUM
ajlm-289	75	112	occurring	occur	VERB
ajlm-289	75	113	in	in	ADP
ajlm-289	75	114	up	up	ADP
ajlm-289	75	115	to	to	PART
ajlm-289	75	116	85	85	NUM
ajlm-289	75	117	%	%	NOUN
ajlm-289	75	118	of	of	ADP
ajlm-289	75	119	cases	case	NOUN
ajlm-289	75	120	and	and	CCONJ
ajlm-289	75	121	trisomy	trisomy	NOUN
ajlm-289	75	122	18	18	NUM
ajlm-289	75	123	in	in	ADP
ajlm-289	75	124	43%.7,16	43%.7,16	NUM
ajlm-289	75	125	all	all	PRON
ajlm-289	75	126	of	of	ADP
ajlm-289	75	127	the	the	DET
ajlm-289	75	128	aberrations	aberration	NOUN
ajlm-289	75	129	described	describe	VERB
ajlm-289	75	130	above	above	ADV
ajlm-289	75	131	were	be	AUX
ajlm-289	75	132	part	part	NOUN
ajlm-289	75	133	of	of	ADP
ajlm-289	75	134	this	this	DET
ajlm-289	75	135	patient	patient	NOUN
ajlm-289	75	136	's	's	PART
ajlm-289	75	137	karyotype	karyotype	NOUN
ajlm-289	75	138	,	,	PUNCT
ajlm-289	75	139	except	except	SCONJ
ajlm-289	75	140	for	for	ADP
ajlm-289	75	141	the	the	DET
ajlm-289	75	142	tp53	tp53	PROPN
ajlm-289	75	143	deletions	deletion	NOUN
ajlm-289	75	144	.	.	PUNCT
ajlm-289	76	1	monosomy	monosomy	NOUN
ajlm-289	76	2	12	12	NUM
ajlm-289	76	3	and	and	CCONJ
ajlm-289	76	4	14	14	NUM
ajlm-289	76	5	have	have	AUX
ajlm-289	76	6	also	also	ADV
ajlm-289	76	7	been	be	AUX
ajlm-289	76	8	reported	report	VERB
ajlm-289	76	9	in	in	ADP
ajlm-289	76	10	primary	primary	ADJ
ajlm-289	76	11	pcl	pcl	PROPN
ajlm-289	76	12	in	in	ADP
ajlm-289	76	13	the	the	DET
ajlm-289	76	14	form	form	NOUN
ajlm-289	76	15	of	of	ADP
ajlm-289	76	16	case	case	NOUN
ajlm-289	76	17	reports.17	reports.17	NOUN
ajlm-289	76	18	poor	poor	ADJ
ajlm-289	76	19	prognostic	prognostic	ADJ
ajlm-289	76	20	factors	factor	NOUN
ajlm-289	76	21	in	in	ADP
ajlm-289	76	22	primary	primary	ADJ
ajlm-289	76	23	pcl	pcl	PROPN
ajlm-289	76	24	include	include	VERB
ajlm-289	76	25	both	both	CCONJ
ajlm-289	76	26	clinical	clinical	ADJ
ajlm-289	76	27	and	and	CCONJ
ajlm-289	76	28	laboratory	laboratory	NOUN
ajlm-289	76	29	parameters.6,7	parameters.6,7	PROPN
ajlm-289	76	30	of	of	ADP
ajlm-289	76	31	these	these	PRON
ajlm-289	76	32	,	,	PUNCT
ajlm-289	76	33	the	the	DET
ajlm-289	76	34	case	case	NOUN
ajlm-289	76	35	study	study	NOUN
ajlm-289	76	36	patient	patient	NOUN
ajlm-289	76	37	presented	present	VERB
ajlm-289	76	38	with	with	ADP
ajlm-289	76	39	a	a	DET
ajlm-289	76	40	performance	performance	NOUN
ajlm-289	76	41	status	status	NOUN
ajlm-289	76	42	score	score	NOUN
ajlm-289	76	43	of	of	ADP
ajlm-289	76	44	≥	≥	NOUN
ajlm-289	76	45	2	2	NUM
ajlm-289	76	46	,	,	PUNCT
ajlm-289	76	47	an	an	DET
ajlm-289	76	48	absolute	absolute	ADJ
ajlm-289	76	49	peripheral	peripheral	ADJ
ajlm-289	76	50	blood	blood	NOUN
ajlm-289	76	51	plasma	plasma	NOUN
ajlm-289	76	52	cell	cell	NOUN
ajlm-289	76	53	count	count	NOUN
ajlm-289	76	54	of	of	ADP
ajlm-289	76	55	>	>	X
ajlm-289	76	56	4	4	NUM
ajlm-289	76	57	×	×	NOUN
ajlm-289	76	58	109	109	NUM
ajlm-289	76	59	/	/	SYM
ajlm-289	76	60	l	l	NOUN
ajlm-289	76	61	,	,	PUNCT
ajlm-289	76	62	thrombocytopenia	thrombocytopenia	PROPN
ajlm-289	76	63	,	,	PUNCT
ajlm-289	76	64	diffuse	diffuse	PROPN
ajlm-289	76	65	marrow	marrow	NOUN
ajlm-289	76	66	infiltration	infiltration	NOUN
ajlm-289	76	67	,	,	PUNCT
ajlm-289	76	68	specific	specific	ADJ
ajlm-289	76	69	cytogenetic	cytogenetic	ADJ
ajlm-289	76	70	abnormalities	abnormality	NOUN
ajlm-289	76	71	,	,	PUNCT
ajlm-289	76	72	including	include	VERB
ajlm-289	76	73	a	a	DET
ajlm-289	76	74	complex	complex	ADJ
ajlm-289	76	75	karyotype	karyotype	NOUN
ajlm-289	76	76	,	,	PUNCT
ajlm-289	76	77	elevated	elevated	ADJ
ajlm-289	76	78	lactate	lactate	NOUN
ajlm-289	76	79	dehydrogenase	dehydrogenase	NOUN
ajlm-289	76	80	,	,	PUNCT
ajlm-289	76	81	elevated	elevate	VERB
ajlm-289	76	82	β2	β2	PROPN
ajlm-289	76	83	microglobulin	microglobulin	PROPN
ajlm-289	76	84	and	and	CCONJ
ajlm-289	76	85	hypercalcaemia	hypercalcaemia	NOUN
ajlm-289	76	86	.	.	PUNCT
ajlm-289	77	1	induction	induction	NOUN
ajlm-289	77	2	therapy	therapy	NOUN
ajlm-289	77	3	failed	fail	VERB
ajlm-289	77	4	to	to	PART
ajlm-289	77	5	induce	induce	VERB
ajlm-289	77	6	remission	remission	NOUN
ajlm-289	77	7	.	.	PUNCT
ajlm-289	78	1	survival	survival	NOUN
ajlm-289	78	2	is	be	AUX
ajlm-289	78	3	known	know	VERB
ajlm-289	78	4	to	to	PART
ajlm-289	78	5	be	be	AUX
ajlm-289	78	6	poor	poor	ADJ
ajlm-289	78	7	in	in	ADP
ajlm-289	78	8	this	this	DET
ajlm-289	78	9	category	category	NOUN
ajlm-289	78	10	of	of	ADP
ajlm-289	78	11	plasma	plasma	NOUN
ajlm-289	78	12	cell	cell	NOUN
ajlm-289	78	13	dyscrasia	dyscrasia	PROPN
ajlm-289	78	14	,	,	PUNCT
ajlm-289	78	15	with	with	ADP
ajlm-289	78	16	28	28	NUM
ajlm-289	78	17	%	%	NOUN
ajlm-289	78	18	of	of	ADP
ajlm-289	78	19	patients	patient	NOUN
ajlm-289	78	20	dying	die	VERB
ajlm-289	78	21	in	in	ADP
ajlm-289	78	22	the	the	DET
ajlm-289	78	23	first	first	ADJ
ajlm-289	78	24	month	month	NOUN
ajlm-289	78	25	following	follow	VERB
ajlm-289	78	26	diagnosis.10	diagnosis.10	ADP
ajlm-289	78	27	the	the	DET
ajlm-289	78	28	average	average	ADJ
ajlm-289	78	29	survival	survival	NOUN
ajlm-289	78	30	for	for	ADP
ajlm-289	78	31	primary	primary	ADJ
ajlm-289	78	32	pcl	pcl	PROPN
ajlm-289	78	33	is	be	AUX
ajlm-289	78	34	11.2	11.2	NUM
ajlm-289	78	35	months.5	months.5	PROPN
ajlm-289	78	36	in	in	ADP
ajlm-289	78	37	general	general	ADJ
ajlm-289	78	38	,	,	PUNCT
ajlm-289	78	39	treatment	treatment	NOUN
ajlm-289	78	40	is	be	AUX
ajlm-289	78	41	aimed	aim	VERB
ajlm-289	78	42	at	at	ADP
ajlm-289	78	43	improving	improve	VERB
ajlm-289	78	44	quality	quality	NOUN
ajlm-289	78	45	of	of	ADP
ajlm-289	78	46	life	life	NOUN
ajlm-289	78	47	and	and	CCONJ
ajlm-289	78	48	prolonging	prolong	VERB
ajlm-289	78	49	survival	survival	NOUN
ajlm-289	78	50	.	.	PUNCT
ajlm-289	79	1	therapy	therapy	NOUN
ajlm-289	79	2	initiation	initiation	NOUN
ajlm-289	79	3	should	should	AUX
ajlm-289	79	4	begin	begin	VERB
ajlm-289	79	5	promptly	promptly	ADV
ajlm-289	79	6	and	and	CCONJ
ajlm-289	79	7	aim	aim	VERB
ajlm-289	79	8	for	for	ADP
ajlm-289	79	9	rapid	rapid	ADJ
ajlm-289	79	10	disease	disease	NOUN
ajlm-289	79	11	control	control	NOUN
ajlm-289	79	12	in	in	ADP
ajlm-289	79	13	an	an	DET
ajlm-289	79	14	attempt	attempt	NOUN
ajlm-289	79	15	to	to	PART
ajlm-289	79	16	prevent	prevent	VERB
ajlm-289	79	17	early	early	ADJ
ajlm-289	79	18	death.11	death.11	ADJ
ajlm-289	79	19	chemotherapy	chemotherapy	NOUN
ajlm-289	79	20	regimens	regimen	NOUN
ajlm-289	79	21	have	have	AUX
ajlm-289	79	22	previously	previously	ADV
ajlm-289	79	23	been	be	AUX
ajlm-289	79	24	based	base	VERB
ajlm-289	79	25	on	on	ADP
ajlm-289	79	26	those	those	PRON
ajlm-289	79	27	used	use	VERB
ajlm-289	79	28	for	for	ADP
ajlm-289	79	29	mm	mm	PROPN
ajlm-289	79	30	,	,	PUNCT
ajlm-289	79	31	with	with	ADP
ajlm-289	79	32	no	no	DET
ajlm-289	79	33	specific	specific	ADJ
ajlm-289	79	34	standard	standard	ADJ
ajlm-289	79	35	protocol	protocol	NOUN
ajlm-289	79	36	available	available	ADJ
ajlm-289	79	37	.	.	PUNCT
ajlm-289	80	1	of	of	ADP
ajlm-289	80	2	these	these	PRON
ajlm-289	80	3	,	,	PUNCT
ajlm-289	80	4	intensive	intensive	ADJ
ajlm-289	80	5	multidrug	multidrug	NOUN
ajlm-289	80	6	regimens	regimen	NOUN
ajlm-289	80	7	with	with	ADP
ajlm-289	80	8	an	an	DET
ajlm-289	80	9	alkylating	alkylate	VERB
ajlm-289	80	10	agent	agent	NOUN
ajlm-289	80	11	as	as	ADP
ajlm-289	80	12	a	a	DET
ajlm-289	80	13	base	base	NOUN
ajlm-289	80	14	have	have	AUX
ajlm-289	80	15	been	be	AUX
ajlm-289	80	16	used	use	VERB
ajlm-289	80	17	with	with	ADP
ajlm-289	80	18	limited	limited	ADJ
ajlm-289	80	19	success	success	NOUN
ajlm-289	80	20	and	and	CCONJ
ajlm-289	80	21	more	more	ADV
ajlm-289	80	22	recently	recently	ADV
ajlm-289	80	23	bortezomib	bortezomib	NOUN
ajlm-289	80	24	-	-	PUNCT
ajlm-289	80	25	based	base	VERB
ajlm-289	80	26	regimens	regimen	NOUN
ajlm-289	80	27	are	be	AUX
ajlm-289	80	28	recommended	recommend	VERB
ajlm-289	80	29	,	,	PUNCT
ajlm-289	80	30	followed	follow	VERB
ajlm-289	80	31	by	by	ADP
ajlm-289	80	32	autologous	autologous	ADJ
ajlm-289	80	33	stem	stem	NOUN
ajlm-289	80	34	cell	cell	NOUN
ajlm-289	80	35	transplantation	transplantation	NOUN
ajlm-289	80	36	,	,	PUNCT
ajlm-289	80	37	if	if	SCONJ
ajlm-289	80	38	feasible.6,10	feasible.6,10	NOUN
ajlm-289	80	39	allogeneic	allogeneic	VERB
ajlm-289	80	40	transplantation	transplantation	NOUN
ajlm-289	80	41	can	can	AUX
ajlm-289	80	42	be	be	AUX
ajlm-289	80	43	considered	consider	VERB
ajlm-289	80	44	in	in	ADP
ajlm-289	80	45	younger	young	ADJ
ajlm-289	80	46	patients.6	patients.6	NOUN
ajlm-289	80	47	our	our	PRON
ajlm-289	80	48	patient	patient	NOUN
ajlm-289	80	49	received	receive	VERB
ajlm-289	80	50	one	one	NUM
ajlm-289	80	51	cycle	cycle	NOUN
ajlm-289	80	52	of	of	ADP
ajlm-289	80	53	induction	induction	NOUN
ajlm-289	80	54	therapy	therapy	NOUN
ajlm-289	80	55	with	with	ADP
ajlm-289	80	56	a	a	DET
ajlm-289	80	57	modified	modify	VERB
ajlm-289	80	58	vincristine	vincristine	NOUN
ajlm-289	80	59	,	,	PUNCT
ajlm-289	80	60	doxorubicin	doxorubicin	PROPN
ajlm-289	80	61	,	,	PUNCT
ajlm-289	80	62	dexamethasone	dexamethasone	NOUN
ajlm-289	80	63	regimen	regiman	NOUN
ajlm-289	80	64	,	,	PUNCT
ajlm-289	80	65	as	as	SCONJ
ajlm-289	80	66	bortezomib	bortezomib	NOUN
ajlm-289	80	67	therapy	therapy	NOUN
ajlm-289	80	68	was	be	AUX
ajlm-289	80	69	not	not	PART
ajlm-289	80	70	available	available	ADJ
ajlm-289	80	71	.	.	PUNCT
ajlm-289	81	1	with	with	SCONJ
ajlm-289	81	2	the	the	DET
ajlm-289	81	3	regimen	regimen	NOUN
ajlm-289	81	4	provided	provide	VERB
ajlm-289	81	5	,	,	PUNCT
ajlm-289	81	6	she	she	PRON
ajlm-289	81	7	never	never	ADV
ajlm-289	81	8	obtained	obtain	VERB
ajlm-289	81	9	complete	complete	ADJ
ajlm-289	81	10	remission	remission	NOUN
ajlm-289	81	11	and	and	CCONJ
ajlm-289	81	12	autologous	autologous	ADJ
ajlm-289	81	13	transplant	transplant	NOUN
ajlm-289	81	14	was	be	AUX
ajlm-289	81	15	not	not	PART
ajlm-289	81	16	possible	possible	ADJ
ajlm-289	81	17	.	.	PUNCT
ajlm-289	82	1	she	she	PRON
ajlm-289	82	2	subsequently	subsequently	ADV
ajlm-289	82	3	received	receive	VERB
ajlm-289	82	4	palliative	palliative	ADJ
ajlm-289	82	5	care	care	NOUN
ajlm-289	82	6	and	and	CCONJ
ajlm-289	82	7	died	die	VERB
ajlm-289	82	8	in	in	ADP
ajlm-289	82	9	hospital	hospital	NOUN
ajlm-289	82	10	seven	seven	NUM
ajlm-289	82	11	months	month	NOUN
ajlm-289	82	12	after	after	ADP
ajlm-289	82	13	the	the	DET
ajlm-289	82	14	initial	initial	ADJ
ajlm-289	82	15	diagnosis	diagnosis	NOUN
ajlm-289	82	16	.	.	PUNCT
ajlm-289	83	1	this	this	DET
ajlm-289	83	2	case	case	NOUN
ajlm-289	83	3	was	be	AUX
ajlm-289	83	4	presented	present	VERB
ajlm-289	83	5	because	because	SCONJ
ajlm-289	83	6	of	of	ADP
ajlm-289	83	7	its	its	PRON
ajlm-289	83	8	rarity	rarity	NOUN
ajlm-289	83	9	and	and	CCONJ
ajlm-289	83	10	the	the	DET
ajlm-289	83	11	young	young	ADJ
ajlm-289	83	12	age	age	NOUN
ajlm-289	83	13	of	of	ADP
ajlm-289	83	14	the	the	DET
ajlm-289	83	15	patient	patient	NOUN
ajlm-289	83	16	at	at	ADP
ajlm-289	83	17	presentation	presentation	NOUN
ajlm-289	83	18	,	,	PUNCT
ajlm-289	83	19	as	as	ADV
ajlm-289	83	20	well	well	ADV
ajlm-289	83	21	as	as	ADP
ajlm-289	83	22	its	its	PRON
ajlm-289	83	23	unusual	unusual	ADJ
ajlm-289	83	24	laboratory	laboratory	NOUN
ajlm-289	83	25	and	and	CCONJ
ajlm-289	83	26	clinical	clinical	ADJ
ajlm-289	83	27	features	feature	NOUN
ajlm-289	83	28	.	.	PUNCT
ajlm-289	84	1	this	this	PRON
ajlm-289	84	2	was	be	AUX
ajlm-289	84	3	an	an	DET
ajlm-289	84	4	unexpected	unexpected	ADJ
ajlm-289	84	5	diagnosis	diagnosis	NOUN
ajlm-289	84	6	and	and	CCONJ
ajlm-289	84	7	,	,	PUNCT
ajlm-289	84	8	not	not	PART
ajlm-289	84	9	surprisingly	surprisingly	ADV
ajlm-289	84	10	,	,	PUNCT
ajlm-289	84	11	the	the	DET
ajlm-289	84	12	diagnosis	diagnosis	NOUN
ajlm-289	84	13	was	be	AUX
ajlm-289	84	14	not	not	PART
ajlm-289	84	15	made	make	VERB
ajlm-289	84	16	at	at	ADP
ajlm-289	84	17	first	first	ADJ
ajlm-289	84	18	presentation	presentation	NOUN
ajlm-289	84	19	.	.	PUNCT
ajlm-289	85	1	a	a	DET
ajlm-289	85	2	history	history	NOUN
ajlm-289	85	3	of	of	ADP
ajlm-289	85	4	recent	recent	ADJ
ajlm-289	85	5	contraceptive	contraceptive	ADJ
ajlm-289	85	6	use	use	NOUN
ajlm-289	85	7	,	,	PUNCT
ajlm-289	85	8	menorrhagia	menorrhagia	NOUN
ajlm-289	85	9	and	and	CCONJ
ajlm-289	85	10	a	a	DET
ajlm-289	85	11	resultant	resultant	NOUN
ajlm-289	85	12	iron	iron	NOUN
ajlm-289	85	13	deficiency	deficiency	NOUN
ajlm-289	85	14	was	be	AUX
ajlm-289	85	15	not	not	PART
ajlm-289	85	16	an	an	DET
ajlm-289	85	17	uncommon	uncommon	ADJ
ajlm-289	85	18	finding	finding	NOUN
ajlm-289	85	19	.	.	PUNCT
ajlm-289	86	1	however	however	ADV
ajlm-289	86	2	,	,	PUNCT
ajlm-289	86	3	additional	additional	ADJ
ajlm-289	86	4	symptoms	symptom	NOUN
ajlm-289	86	5	were	be	AUX
ajlm-289	86	6	also	also	ADV
ajlm-289	86	7	noted	note	VERB
ajlm-289	86	8	and	and	CCONJ
ajlm-289	86	9	the	the	DET
ajlm-289	86	10	patient	patient	NOUN
ajlm-289	86	11	had	have	VERB
ajlm-289	86	12	no	no	DET
ajlm-289	86	13	improvement	improvement	NOUN
ajlm-289	86	14	,	,	PUNCT
ajlm-289	86	15	despite	despite	SCONJ
ajlm-289	86	16	iron	iron	NOUN
ajlm-289	86	17	supplementation	supplementation	NOUN
ajlm-289	86	18	.	.	PUNCT
ajlm-289	87	1	a	a	DET
ajlm-289	87	2	high	high	ADJ
ajlm-289	87	3	index	index	NOUN
ajlm-289	87	4	of	of	ADP
ajlm-289	87	5	suspicion	suspicion	NOUN
ajlm-289	87	6	,	,	PUNCT
ajlm-289	87	7	together	together	ADV
ajlm-289	87	8	with	with	ADP
ajlm-289	87	9	early	early	ADJ
ajlm-289	87	10	referral	referral	NOUN
ajlm-289	87	11	and	and	CCONJ
ajlm-289	87	12	the	the	DET
ajlm-289	87	13	use	use	NOUN
ajlm-289	87	14	of	of	ADP
ajlm-289	87	15	basic	basic	ADJ
ajlm-289	87	16	first	first	ADJ
ajlm-289	87	17	line	line	NOUN
ajlm-289	87	18	investigations	investigation	NOUN
ajlm-289	87	19	,	,	PUNCT
ajlm-289	87	20	such	such	ADJ
ajlm-289	87	21	as	as	ADP
ajlm-289	87	22	differential	differential	ADJ
ajlm-289	87	23	count	count	NOUN
ajlm-289	87	24	,	,	PUNCT
ajlm-289	87	25	should	should	AUX
ajlm-289	87	26	be	be	AUX
ajlm-289	87	27	advocated	advocate	VERB
ajlm-289	87	28	.	.	PUNCT
ajlm-289	88	1	the	the	DET
ajlm-289	88	2	inaccessibility	inaccessibility	NOUN
ajlm-289	88	3	of	of	ADP
ajlm-289	88	4	the	the	DET
ajlm-289	88	5	recommended	recommend	VERB
ajlm-289	88	6	drug	drug	NOUN
ajlm-289	88	7	therapy	therapy	NOUN
ajlm-289	88	8	was	be	AUX
ajlm-289	88	9	also	also	ADV
ajlm-289	88	10	likely	likely	ADJ
ajlm-289	88	11	to	to	PART
ajlm-289	88	12	have	have	AUX
ajlm-289	88	13	affected	affect	VERB
ajlm-289	88	14	survival	survival	NOUN
ajlm-289	88	15	and	and	CCONJ
ajlm-289	88	16	diminished	diminish	VERB
ajlm-289	88	17	chances	chance	NOUN
ajlm-289	88	18	for	for	ADP
ajlm-289	88	19	possible	possible	ADJ
ajlm-289	88	20	stem	stem	NOUN
ajlm-289	88	21	-	-	PUNCT
ajlm-289	88	22	cell	cell	NOUN
ajlm-289	88	23	transplant	transplant	NOUN
ajlm-289	88	24	.	.	PUNCT
ajlm-289	89	1	it	it	PRON
ajlm-289	89	2	is	be	AUX
ajlm-289	89	3	vital	vital	ADJ
ajlm-289	89	4	to	to	PART
ajlm-289	89	5	make	make	VERB
ajlm-289	89	6	an	an	DET
ajlm-289	89	7	early	early	ADJ
ajlm-289	89	8	diagnosis	diagnosis	NOUN
ajlm-289	89	9	of	of	ADP
ajlm-289	89	10	haematological	haematological	ADJ
ajlm-289	89	11	and	and	CCONJ
ajlm-289	89	12	other	other	ADJ
ajlm-289	89	13	malignancies	malignancy	NOUN
ajlm-289	89	14	in	in	ADP
ajlm-289	89	15	our	our	PRON
ajlm-289	89	16	setting	setting	NOUN
ajlm-289	89	17	where	where	SCONJ
ajlm-289	89	18	treatment	treatment	NOUN
ajlm-289	89	19	options	option	NOUN
ajlm-289	89	20	are	be	AUX
ajlm-289	89	21	already	already	ADV
ajlm-289	89	22	limited	limited	ADJ
ajlm-289	89	23	and	and	CCONJ
ajlm-289	89	24	delayed	delay	VERB
ajlm-289	89	25	diagnosis	diagnosis	NOUN
ajlm-289	89	26	may	may	AUX
ajlm-289	89	27	negatively	negatively	ADV
ajlm-289	89	28	impact	impact	VERB
ajlm-289	89	29	prognosis	prognosis	NOUN
ajlm-289	89	30	.	.	PUNCT
ajlm-289	90	1	acknowledgements	acknowledgement	NOUN
ajlm-289	90	2	top	top	PROPN
ajlm-289	90	3	↑	↑	PROPN
ajlm-289	90	4	karyotyping	karyotyping	NOUN
ajlm-289	90	5	and	and	CCONJ
ajlm-289	90	6	fluorescence	fluorescence	NOUN
ajlm-289	90	7	in	in	ADP
ajlm-289	90	8	situ	situ	ADJ
ajlm-289	90	9	hybridisation	hybridisation	NOUN
ajlm-289	90	10	analyses	analysis	NOUN
ajlm-289	90	11	were	be	AUX
ajlm-289	90	12	performed	perform	VERB
ajlm-289	90	13	in	in	ADP
ajlm-289	90	14	the	the	DET
ajlm-289	90	15	somatic	somatic	ADJ
ajlm-289	90	16	cell	cell	NOUN
ajlm-289	90	17	genetics	genetic	NOUN
ajlm-289	90	18	unit	unit	NOUN
ajlm-289	90	19	,	,	PUNCT
ajlm-289	90	20	department	department	NOUN
ajlm-289	90	21	of	of	ADP
ajlm-289	90	22	molecular	molecular	ADJ
ajlm-289	90	23	medicine	medicine	NOUN
ajlm-289	90	24	and	and	CCONJ
ajlm-289	90	25	haematology	haematology	NOUN
ajlm-289	90	26	,	,	PUNCT
ajlm-289	90	27	university	university	NOUN
ajlm-289	90	28	of	of	ADP
ajlm-289	90	29	the	the	DET
ajlm-289	90	30	witwatersrand	witwatersrand	NOUN
ajlm-289	90	31	,	,	PUNCT
ajlm-289	90	32	johannesburg	johannesburg	PROPN
ajlm-289	90	33	,	,	PUNCT
ajlm-289	90	34	south	south	PROPN
ajlm-289	90	35	africa	africa	PROPN
ajlm-289	90	36	.	.	PUNCT
ajlm-289	91	1	competing	compete	VERB
ajlm-289	91	2	interests	interest	NOUN
ajlm-289	91	3	the	the	DET
ajlm-289	91	4	authors	author	NOUN
ajlm-289	91	5	declare	declare	VERB
ajlm-289	91	6	that	that	SCONJ
ajlm-289	91	7	they	they	PRON
ajlm-289	91	8	have	have	VERB
ajlm-289	91	9	no	no	DET
ajlm-289	91	10	financial	financial	ADJ
ajlm-289	91	11	or	or	CCONJ
ajlm-289	91	12	personal	personal	ADJ
ajlm-289	91	13	relationship(s	relationship(s	NOUN
ajlm-289	91	14	)	)	PUNCT
ajlm-289	91	15	that	that	PRON
ajlm-289	91	16	may	may	AUX
ajlm-289	91	17	have	have	AUX
ajlm-289	91	18	inappropriately	inappropriately	ADV
ajlm-289	91	19	influenced	influence	VERB
ajlm-289	91	20	them	they	PRON
ajlm-289	91	21	in	in	ADP
ajlm-289	91	22	writing	write	VERB
ajlm-289	91	23	this	this	DET
ajlm-289	91	24	article	article	NOUN
ajlm-289	91	25	.	.	PUNCT
ajlm-289	92	1	authors	author	NOUN
ajlm-289	92	2	’	’	PART
ajlm-289	92	3	contributions	contribution	NOUN
ajlm-289	92	4	r.m	r.m	PROPN
ajlm-289	92	5	.	.	PUNCT
ajlm-289	93	1	(	(	PUNCT
ajlm-289	93	2	university	university	NOUN
ajlm-289	93	3	of	of	ADP
ajlm-289	93	4	the	the	DET
ajlm-289	93	5	witwatersrand	witwatersrand	NOUN
ajlm-289	93	6	and	and	CCONJ
ajlm-289	93	7	national	national	PROPN
ajlm-289	93	8	health	health	PROPN
ajlm-289	93	9	laboratory	laboratory	PROPN
ajlm-289	93	10	service	service	PROPN
ajlm-289	93	11	)	)	PUNCT
ajlm-289	93	12	was	be	AUX
ajlm-289	93	13	involved	involve	VERB
ajlm-289	93	14	with	with	ADP
ajlm-289	93	15	the	the	DET
ajlm-289	93	16	concept	concept	NOUN
ajlm-289	93	17	and	and	CCONJ
ajlm-289	93	18	design	design	NOUN
ajlm-289	93	19	,	,	PUNCT
ajlm-289	93	20	data	datum	NOUN
ajlm-289	93	21	collection	collection	NOUN
ajlm-289	93	22	and	and	CCONJ
ajlm-289	93	23	writing	writing	NOUN
ajlm-289	93	24	of	of	ADP
ajlm-289	93	25	the	the	DET
ajlm-289	93	26	article	article	NOUN
ajlm-289	93	27	and	and	CCONJ
ajlm-289	93	28	takes	take	VERB
ajlm-289	93	29	on	on	ADP
ajlm-289	93	30	the	the	DET
ajlm-289	93	31	overall	overall	ADJ
ajlm-289	93	32	responsibility	responsibility	NOUN
ajlm-289	93	33	for	for	ADP
ajlm-289	93	34	the	the	DET
ajlm-289	93	35	article	article	NOUN
ajlm-289	93	36	.	.	PUNCT
ajlm-289	94	1	j.v	j.v	PROPN
ajlm-289	94	2	.	.	PROPN
ajlm-289	95	1	and	and	CCONJ
ajlm-289	95	2	e.s	e.s	PROPN
ajlm-289	95	3	.	.	PROPN
ajlm-289	95	4	(	(	PUNCT
ajlm-289	95	5	university	university	NOUN
ajlm-289	95	6	of	of	ADP
ajlm-289	95	7	the	the	DET
ajlm-289	95	8	witwatersrand	witwatersrand	NOUN
ajlm-289	95	9	and	and	CCONJ
ajlm-289	95	10	national	national	PROPN
ajlm-289	95	11	health	health	PROPN
ajlm-289	95	12	laboratory	laboratory	PROPN
ajlm-289	95	13	service	service	PROPN
ajlm-289	95	14	)	)	PUNCT
ajlm-289	95	15	were	be	AUX
ajlm-289	95	16	responsible	responsible	ADJ
ajlm-289	95	17	for	for	ADP
ajlm-289	95	18	data	data	NOUN
ajlm-289	95	19	collection	collection	NOUN
ajlm-289	95	20	and	and	CCONJ
ajlm-289	95	21	critical	critical	ADJ
ajlm-289	95	22	revision	revision	NOUN
ajlm-289	95	23	of	of	ADP
ajlm-289	95	24	the	the	DET
ajlm-289	95	25	article	article	NOUN
ajlm-289	95	26	.	.	PUNCT
ajlm-289	96	1	s.c	s.c	PROPN
ajlm-289	96	2	.	.	PROPN
ajlm-289	96	3	and	and	CCONJ
ajlm-289	96	4	t.w	t.w	PROPN
ajlm-289	96	5	.	.	PROPN
ajlm-289	96	6	(	(	PUNCT
ajlm-289	96	7	university	university	NOUN
ajlm-289	96	8	of	of	ADP
ajlm-289	96	9	the	the	DET
ajlm-289	96	10	witwatersrand	witwatersrand	NOUN
ajlm-289	96	11	and	and	CCONJ
ajlm-289	96	12	national	national	PROPN
ajlm-289	96	13	health	health	PROPN
ajlm-289	96	14	laboratory	laboratory	PROPN
ajlm-289	96	15	service	service	PROPN
ajlm-289	96	16	)	)	PUNCT
ajlm-289	96	17	were	be	AUX
ajlm-289	96	18	responsible	responsible	ADJ
ajlm-289	96	19	for	for	ADP
ajlm-289	96	20	critical	critical	ADJ
ajlm-289	96	21	revision	revision	NOUN
ajlm-289	96	22	and	and	CCONJ
ajlm-289	96	23	final	final	ADJ
ajlm-289	96	24	approval	approval	NOUN
ajlm-289	96	25	of	of	ADP
ajlm-289	96	26	the	the	DET
ajlm-289	96	27	article	article	NOUN
ajlm-289	96	28	.	.	PUNCT
ajlm-289	97	1	r.d	r.d	PROPN
ajlm-289	97	2	.	.	PUNCT
ajlm-289	98	1	(	(	PUNCT
ajlm-289	98	2	university	university	NOUN
ajlm-289	98	3	of	of	ADP
ajlm-289	98	4	the	the	DET
ajlm-289	98	5	witwatersrand	witwatersrand	NOUN
ajlm-289	98	6	)	)	PUNCT
ajlm-289	98	7	was	be	AUX
ajlm-289	98	8	responsible	responsible	ADJ
ajlm-289	98	9	for	for	ADP
ajlm-289	98	10	data	data	NOUN
ajlm-289	98	11	collection	collection	NOUN
ajlm-289	98	12	and	and	CCONJ
ajlm-289	98	13	critical	critical	ADJ
ajlm-289	98	14	revision	revision	NOUN
ajlm-289	98	15	of	of	ADP
ajlm-289	98	16	the	the	DET
ajlm-289	98	17	article	article	NOUN
ajlm-289	98	18	.	.	PUNCT
ajlm-289	99	1	references	reference	NOUN
ajlm-289	99	2	top	top	PROPN
ajlm-289	99	3	↑	↑	PROPN
ajlm-289	99	4	dimopoulos	dimopoulos	PROPN
ajlm-289	99	5	ma	ma	PROPN
ajlm-289	99	6	,	,	PUNCT
ajlm-289	99	7	palumbo	palumbo	PROPN
ajlm-289	99	8	a	a	DET
ajlm-289	99	9	,	,	PUNCT
ajlm-289	99	10	delasalle	delasalle	PROPN
ajlm-289	99	11	kb	kb	PROPN
ajlm-289	99	12	,	,	PUNCT
ajlm-289	99	13	alexanian	alexanian	PROPN
ajlm-289	99	14	r.	r.	PROPN
ajlm-289	99	15	primary	primary	ADJ
ajlm-289	99	16	plasma	plasma	NOUN
ajlm-289	99	17	cell	cell	NOUN
ajlm-289	99	18	leukaemia	leukaemia	NOUN
ajlm-289	99	19	.	.	PUNCT
ajlm-289	100	1	br	br	X
ajlm-289	100	2	j	j	PROPN
ajlm-289	100	3	haematol	haematol	NOUN
ajlm-289	100	4	.	.	PUNCT
ajlm-289	101	1	1994;88(4):754–759	1994;88(4):754–759	NUM
ajlm-289	101	2	.	.	PUNCT
ajlm-289	102	1	pmid	pmid	NOUN
ajlm-289	102	2	:	:	PUNCT
ajlm-289	102	3	7819100	7819100	NUM
ajlm-289	102	4	.	.	PUNCT
ajlm-289	103	1	kyle	kyle	PROPN
ajlm-289	103	2	ra	ra	PROPN
ajlm-289	103	3	,	,	PUNCT
ajlm-289	103	4	maldonado	maldonado	PROPN
ajlm-289	103	5	je	je	PROPN
ajlm-289	103	6	,	,	PUNCT
ajlm-289	103	7	bayrd	bayrd	VERB
ajlm-289	103	8	ed	ed	NOUN
ajlm-289	103	9	.	.	PUNCT
ajlm-289	104	1	plasma	plasma	NOUN
ajlm-289	104	2	cell	cell	NOUN
ajlm-289	104	3	leukemia	leukemia	NOUN
ajlm-289	104	4	.	.	PUNCT
ajlm-289	105	1	report	report	NOUN
ajlm-289	105	2	on	on	ADP
ajlm-289	105	3	17	17	NUM
ajlm-289	105	4	cases	case	NOUN
ajlm-289	105	5	.	.	PUNCT
ajlm-289	106	1	arch	arch	ADJ
ajlm-289	106	2	intern	intern	NOUN
ajlm-289	106	3	med	me	VERB
ajlm-289	106	4	.	.	PUNCT
ajlm-289	107	1	1974;133(5):813–818	1974;133(5):813–818	NUM
ajlm-289	107	2	.	.	PUNCT
ajlm-289	108	1	pmid	pmid	NOUN
ajlm-289	108	2	:	:	PUNCT
ajlm-289	108	3	4821776	4821776	NUM
ajlm-289	108	4	.	.	PUNCT
ajlm-289	109	1	international	international	ADJ
ajlm-289	109	2	myeloma	myeloma	PROPN
ajlm-289	109	3	working	work	VERB
ajlm-289	109	4	group.criteria	group.criteria	NUM
ajlm-289	109	5	for	for	ADP
ajlm-289	109	6	the	the	DET
ajlm-289	109	7	classification	classification	NOUN
ajlm-289	109	8	of	of	ADP
ajlm-289	109	9	monoclonal	monoclonal	NOUN
ajlm-289	109	10	gammopathies	gammopathy	NOUN
ajlm-289	109	11	,	,	PUNCT
ajlm-289	109	12	multiple	multiple	ADJ
ajlm-289	109	13	myeloma	myeloma	NOUN
ajlm-289	109	14	and	and	CCONJ
ajlm-289	109	15	related	related	ADJ
ajlm-289	109	16	disorders	disorder	NOUN
ajlm-289	109	17	:	:	PUNCT
ajlm-289	109	18	a	a	DET
ajlm-289	109	19	report	report	NOUN
ajlm-289	109	20	of	of	ADP
ajlm-289	109	21	the	the	DET
ajlm-289	109	22	international	international	ADJ
ajlm-289	109	23	myeloma	myeloma	PROPN
ajlm-289	109	24	working	working	NOUN
ajlm-289	109	25	group	group	NOUN
ajlm-289	109	26	.	.	PUNCT
ajlm-289	110	1	br	br	PROPN
ajlm-289	110	2	j	j	PROPN
ajlm-289	110	3	haematol	haematol	NOUN
ajlm-289	110	4	.	.	PUNCT
ajlm-289	111	1	2003;121(5):749–757	2003;121(5):749–757	NOUN
ajlm-289	111	2	.	.	PUNCT
ajlm-289	112	1	pmid	pmid	NOUN
ajlm-289	112	2	:	:	PUNCT
ajlm-289	112	3	12780789	12780789	NUM
ajlm-289	112	4	.	.	PUNCT
ajlm-289	113	1	mosca	mosca	PROPN
ajlm-289	113	2	l	l	PROPN
ajlm-289	113	3	,	,	PUNCT
ajlm-289	113	4	musto	musto	NOUN
ajlm-289	113	5	p	p	PROPN
ajlm-289	113	6	,	,	PUNCT
ajlm-289	113	7	todoerti	todoerti	PROPN
ajlm-289	113	8	k	k	PROPN
ajlm-289	113	9	,	,	PUNCT
ajlm-289	113	10	et	et	PROPN
ajlm-289	113	11	al	al	PROPN
ajlm-289	113	12	.	.	PUNCT
ajlm-289	113	13	genome	genome	NOUN
ajlm-289	113	14	-	-	PUNCT
ajlm-289	113	15	wide	wide	ADJ
ajlm-289	113	16	analysis	analysis	NOUN
ajlm-289	113	17	of	of	ADP
ajlm-289	113	18	primary	primary	ADJ
ajlm-289	113	19	plasma	plasma	NOUN
ajlm-289	113	20	cell	cell	NOUN
ajlm-289	113	21	leukemia	leukemia	NOUN
ajlm-289	113	22	identifies	identify	VERB
ajlm-289	113	23	recurrent	recurrent	ADJ
ajlm-289	113	24	imbalances	imbalance	NOUN
ajlm-289	113	25	associated	associate	VERB
ajlm-289	113	26	with	with	ADP
ajlm-289	113	27	changes	change	NOUN
ajlm-289	113	28	in	in	ADP
ajlm-289	113	29	transcriptional	transcriptional	ADJ
ajlm-289	113	30	profiles	profile	NOUN
ajlm-289	113	31	.	.	PUNCT
ajlm-289	114	1	am	be	AUX
ajlm-289	114	2	j	j	PROPN
ajlm-289	114	3	hematol	hematol	NOUN
ajlm-289	114	4	.	.	PUNCT
ajlm-289	115	1	2013;88(1):16–23	2013;88(1):16–23	X
ajlm-289	115	2	.	.	PUNCT
ajlm-289	116	1	pmid	pmid	NOUN
ajlm-289	116	2	:	:	PUNCT
ajlm-289	116	3	23044976	23044976	NUM
ajlm-289	116	4	,	,	PUNCT
ajlm-289	116	5	http://dx.doi.org/10.1002/ajh.23339	http://dx.doi.org/10.1002/ajh.23339	PROPN
ajlm-289	116	6	tiedemann	tiedemann	PROPN
ajlm-289	116	7	re	re	PROPN
ajlm-289	116	8	,	,	PUNCT
ajlm-289	116	9	gonzalez	gonzalez	PROPN
ajlm-289	116	10	-	-	PUNCT
ajlm-289	116	11	paz	paz	PROPN
ajlm-289	116	12	n	n	CCONJ
ajlm-289	116	13	,	,	PUNCT
ajlm-289	116	14	kyle	kyle	PROPN
ajlm-289	116	15	ra	ra	PROPN
ajlm-289	116	16	,	,	PUNCT
ajlm-289	116	17	et	et	PROPN
ajlm-289	116	18	al	al	PROPN
ajlm-289	116	19	.	.	PUNCT
ajlm-289	117	1	genetic	genetic	ADJ
ajlm-289	117	2	aberrations	aberration	NOUN
ajlm-289	117	3	and	and	CCONJ
ajlm-289	117	4	survival	survival	NOUN
ajlm-289	117	5	in	in	ADP
ajlm-289	117	6	plasma	plasma	NOUN
ajlm-289	117	7	cell	cell	NOUN
ajlm-289	117	8	leukemia	leukemia	NOUN
ajlm-289	117	9	.	.	PUNCT
ajlm-289	118	1	leukemia	leukemia	NOUN
ajlm-289	118	2	.	.	PUNCT
ajlm-289	119	1	2008;22(5):1044–1052	2008;22(5):1044–1052	NUM
ajlm-289	119	2	.	.	PUNCT
ajlm-289	120	1	pmid	pmid	NOUN
ajlm-289	120	2	:	:	PUNCT
ajlm-289	120	3	18216867	18216867	NUM
ajlm-289	120	4	,	,	PUNCT
ajlm-289	120	5	http://dx.doi.org/10.1038/leu.2008.4	http://dx.doi.org/10.1038/leu.2008.4	PROPN
ajlm-289	120	6	van	van	PROPN
ajlm-289	120	7	de	de	PROPN
ajlm-289	120	8	donk	donk	PROPN
ajlm-289	120	9	nw	nw	PROPN
ajlm-289	120	10	,	,	PUNCT
ajlm-289	120	11	lokhorst	lokhorst	VERB
ajlm-289	120	12	hm	hm	INTJ
ajlm-289	120	13	,	,	PUNCT
ajlm-289	120	14	anderson	anderson	PROPN
ajlm-289	120	15	kc	kc	PROPN
ajlm-289	120	16	,	,	PUNCT
ajlm-289	120	17	richardson	richardson	PROPN
ajlm-289	120	18	pg	pg	PROPN
ajlm-289	120	19	.	.	PUNCT
ajlm-289	121	1	how	how	SCONJ
ajlm-289	121	2	i	i	PRON
ajlm-289	121	3	treat	treat	VERB
ajlm-289	121	4	plasma	plasma	NOUN
ajlm-289	121	5	cell	cell	NOUN
ajlm-289	121	6	leukemia	leukemia	NOUN
ajlm-289	121	7	.	.	PUNCT
ajlm-289	122	1	blood	blood	NOUN
ajlm-289	122	2	.	.	PUNCT
ajlm-289	123	1	2012;120(12):2376–2389.pmid	2012;120(12):2376–2389.pmid	NUM
ajlm-289	123	2	:	:	PUNCT
ajlm-289	123	3	22837533	22837533	NUM
ajlm-289	123	4	,	,	PUNCT
ajlm-289	123	5	http://dx.doi.org/10.1182/blood-2012-05-408682	http://dx.doi.org/10.1182/blood-2012-05-408682	ADV
ajlm-289	123	6	garcia	garcia	PROPN
ajlm-289	123	7	-	-	PUNCT
ajlm-289	123	8	sanz	sanz	PROPN
ajlm-289	123	9	r	r	PROPN
ajlm-289	123	10	,	,	PUNCT
ajlm-289	123	11	orfão	orfão	PROPN
ajlm-289	123	12	a	a	PRON
ajlm-289	123	13	,	,	PUNCT
ajlm-289	123	14	gonzález	gonzález	PROPN
ajlm-289	123	15	m	m	PROPN
ajlm-289	123	16	,	,	PUNCT
ajlm-289	123	17	et	et	PROPN
ajlm-289	123	18	al	al	PROPN
ajlm-289	123	19	.	.	PROPN
ajlm-289	123	20	primary	primary	ADJ
ajlm-289	123	21	plasma	plasma	NOUN
ajlm-289	123	22	cell	cell	NOUN
ajlm-289	123	23	leukemia	leukemia	NOUN
ajlm-289	123	24	:	:	PUNCT
ajlm-289	123	25	clinical	clinical	ADJ
ajlm-289	123	26	,	,	PUNCT
ajlm-289	123	27	immunophenotypic	immunophenotypic	ADJ
ajlm-289	123	28	,	,	PUNCT
ajlm-289	123	29	dna	dna	NOUN
ajlm-289	123	30	ploidy	ploidy	NOUN
ajlm-289	123	31	,	,	PUNCT
ajlm-289	123	32	and	and	CCONJ
ajlm-289	123	33	cytogenetic	cytogenetic	ADJ
ajlm-289	123	34	characteristics	characteristic	NOUN
ajlm-289	123	35	.	.	PUNCT
ajlm-289	124	1	blood	blood	NOUN
ajlm-289	124	2	.	.	PUNCT
ajlm-289	125	1	1999;93(3):1032–1037	1999;93(3):1032–1037	NUM
ajlm-289	125	2	.	.	PUNCT
ajlm-289	126	1	pmid	pmid	NOUN
ajlm-289	126	2	:	:	PUNCT
ajlm-289	126	3	9920853	9920853	NUM
ajlm-289	126	4	.	.	PUNCT
ajlm-289	127	1	jain	jain	PROPN
ajlm-289	127	2	d	d	PROPN
ajlm-289	127	3	,	,	PUNCT
ajlm-289	127	4	singh	singh	PROPN
ajlm-289	127	5	t	t	PROPN
ajlm-289	127	6	,	,	PUNCT
ajlm-289	127	7	akhila	akhila	NOUN
ajlm-289	127	8	l	l	NOUN
ajlm-289	127	9	,	,	PUNCT
ajlm-289	127	10	ghosh	ghosh	PROPN
ajlm-289	127	11	n.	n.	PROPN
ajlm-289	127	12	primary	primary	ADJ
ajlm-289	127	13	plasma	plasma	NOUN
ajlm-289	127	14	cell	cell	NOUN
ajlm-289	127	15	leukemia	leukemia	NOUN
ajlm-289	127	16	in	in	ADP
ajlm-289	127	17	a	a	DET
ajlm-289	127	18	30	30	NUM
ajlm-289	127	19	-	-	PUNCT
ajlm-289	127	20	year	year	NOUN
ajlm-289	127	21	-	-	PUNCT
ajlm-289	127	22	old	old	ADJ
ajlm-289	127	23	woman	woman	NOUN
ajlm-289	127	24	.	.	PUNCT
ajlm-289	128	1	indian	indian	PROPN
ajlm-289	128	2	j	j	PROPN
ajlm-289	128	3	pathol	pathol	VERB
ajlm-289	128	4	microbiol	microbiol	NOUN
ajlm-289	128	5	.	.	PUNCT
ajlm-289	129	1	2008;51(3):456–457	2008;51(3):456–457	NUM
ajlm-289	129	2	.	.	PUNCT
ajlm-289	130	1	pmid	pmid	NOUN
ajlm-289	130	2	:	:	PUNCT
ajlm-289	130	3	18723997	18723997	NUM
ajlm-289	130	4	.	.	PUNCT
ajlm-289	131	1	raj	raj	PROPN
ajlm-289	131	2	rs	rs	PROPN
ajlm-289	131	3	,	,	PUNCT
ajlm-289	131	4	najeeb	najeeb	PROPN
ajlm-289	131	5	s	s	PART
ajlm-289	131	6	,	,	PUNCT
ajlm-289	131	7	aruna	aruna	PROPN
ajlm-289	131	8	r	r	PROPN
ajlm-289	131	9	,	,	PUNCT
ajlm-289	131	10	pavithran	pavithran	ADJ
ajlm-289	131	11	k	k	NOUN
ajlm-289	131	12	,	,	PUNCT
ajlm-289	131	13	thomas	thomas	PROPN
ajlm-289	131	14	m.	m.	PROPN
ajlm-289	131	15	primary	primary	ADJ
ajlm-289	131	16	plasma	plasma	NOUN
ajlm-289	131	17	cell	cell	NOUN
ajlm-289	131	18	leukemia	leukemia	NOUN
ajlm-289	131	19	occuring	occur	VERB
ajlm-289	131	20	in	in	ADP
ajlm-289	131	21	the	the	DET
ajlm-289	131	22	young	young	ADJ
ajlm-289	131	23	.	.	PUNCT
ajlm-289	132	1	indian	indian	PROPN
ajlm-289	132	2	j	j	PROPN
ajlm-289	132	3	cancer	cancer	NOUN
ajlm-289	132	4	.	.	PUNCT
ajlm-289	133	1	2003;40(3):116–117	2003;40(3):116–117	X
ajlm-289	133	2	.	.	PUNCT
ajlm-289	134	1	pmid	pmid	NOUN
ajlm-289	134	2	:	:	PUNCT
ajlm-289	134	3	14716116	14716116	NUM
ajlm-289	134	4	.	.	PUNCT
ajlm-289	135	1	albarracin	albarracin	PROPN
ajlm-289	135	2	f	f	PROPN
ajlm-289	135	3	,	,	PUNCT
ajlm-289	135	4	fonseca	fonseca	PROPN
ajlm-289	135	5	r.	r.	PROPN
ajlm-289	135	6	plasma	plasma	PROPN
ajlm-289	135	7	cell	cell	NOUN
ajlm-289	135	8	leukemia	leukemia	NOUN
ajlm-289	135	9	.	.	PUNCT
ajlm-289	136	1	blood	blood	NOUN
ajlm-289	136	2	rev	rev	VERB
ajlm-289	136	3	.	.	PUNCT
ajlm-289	137	1	2011;25(3):107–112.pmid	2011;25(3):107–112.pmid	NOUN
ajlm-289	137	2	:	:	PUNCT
ajlm-289	137	3	21295388	21295388	NUM
ajlm-289	137	4	,	,	PUNCT
ajlm-289	137	5	http://dx.doi.org/10.1016/j.blre.2011.01.005	http://dx.doi.org/10.1016/j.blre.2011.01.005	PROPN
ajlm-289	137	6	fernández	fernández	PROPN
ajlm-289	137	7	de	de	X
ajlm-289	137	8	larrea	larrea	PROPN
ajlm-289	137	9	c	c	PROPN
ajlm-289	137	10	,	,	PUNCT
ajlm-289	137	11	kyle	kyle	PROPN
ajlm-289	137	12	ra	ra	PROPN
ajlm-289	137	13	,	,	PUNCT
ajlm-289	137	14	durie	durie	VERB
ajlm-289	137	15	bg	bg	PROPN
ajlm-289	137	16	,	,	PUNCT
ajlm-289	137	17	et	et	PROPN
ajlm-289	137	18	al	al	PROPN
ajlm-289	137	19	.	.	PUNCT
ajlm-289	137	20	plasma	plasma	NOUN
ajlm-289	137	21	cell	cell	NOUN
ajlm-289	137	22	leukemia	leukemia	NOUN
ajlm-289	137	23	:	:	PUNCT
ajlm-289	137	24	consensus	consensus	NOUN
ajlm-289	137	25	statement	statement	NOUN
ajlm-289	137	26	on	on	ADP
ajlm-289	137	27	diagnostic	diagnostic	ADJ
ajlm-289	137	28	requirements	requirement	NOUN
ajlm-289	137	29	,	,	PUNCT
ajlm-289	137	30	response	response	NOUN
ajlm-289	137	31	criteria	criterion	NOUN
ajlm-289	137	32	and	and	CCONJ
ajlm-289	137	33	treatment	treatment	NOUN
ajlm-289	137	34	recommendations	recommendation	NOUN
ajlm-289	137	35	by	by	ADP
ajlm-289	137	36	the	the	DET
ajlm-289	137	37	international	international	ADJ
ajlm-289	137	38	myeloma	myeloma	PROPN
ajlm-289	137	39	working	working	NOUN
ajlm-289	137	40	group	group	NOUN
ajlm-289	137	41	.	.	PUNCT
ajlm-289	138	1	leukemia	leukemia	NOUN
ajlm-289	138	2	.	.	PUNCT
ajlm-289	139	1	2013;27(4):780–791	2013;27(4):780–791	X
ajlm-289	139	2	.	.	PUNCT
ajlm-289	140	1	pmid	pmid	NOUN
ajlm-289	140	2	:	:	PUNCT
ajlm-289	140	3	23288300	23288300	NUM
ajlm-289	140	4	,	,	PUNCT
ajlm-289	140	5	http://dx.doi.org/10.1038/leu.2012.336	http://dx.doi.org/10.1038/leu.2012.336	VERB
ajlm-289	140	6	chiecchio	chiecchio	ADJ
ajlm-289	140	7	l	l	NOUN
ajlm-289	140	8	,	,	PUNCT
ajlm-289	140	9	dagrada	dagrada	PROPN
ajlm-289	140	10	gp	gp	PROPN
ajlm-289	140	11	,	,	PUNCT
ajlm-289	140	12	white	white	ADJ
ajlm-289	140	13	he	he	PRON
ajlm-289	140	14	,	,	PUNCT
ajlm-289	140	15	et	et	PROPN
ajlm-289	140	16	al	al	PROPN
ajlm-289	140	17	.	.	PUNCT
ajlm-289	140	18	frequent	frequent	ADJ
ajlm-289	140	19	upregulation	upregulation	NOUN
ajlm-289	140	20	of	of	ADP
ajlm-289	140	21	myc	myc	PROPN
ajlm-289	140	22	in	in	ADP
ajlm-289	140	23	plasma	plasma	NOUN
ajlm-289	140	24	cell	cell	NOUN
ajlm-289	140	25	leukemia	leukemia	NOUN
ajlm-289	140	26	.	.	PUNCT
ajlm-289	141	1	genes	gene	NOUN
ajlm-289	141	2	chromosomes	chromosome	NOUN
ajlm-289	141	3	cancer	cancer	NOUN
ajlm-289	141	4	.	.	PUNCT
ajlm-289	142	1	2009;48(7):624–636	2009;48(7):624–636	X
ajlm-289	142	2	.	.	PUNCT
ajlm-289	143	1	pmid	pmid	NOUN
ajlm-289	143	2	:	:	PUNCT
ajlm-289	143	3	19396865	19396865	NUM
ajlm-289	143	4	,	,	PUNCT
ajlm-289	143	5	http://dx.doi.org/10.1002/gcc.20670	http://dx.doi.org/10.1002/gcc.20670	PROPN
ajlm-289	143	6	lorsbach	lorsbach	NOUN
ajlm-289	143	7	rb	rb	NOUN
ajlm-289	143	8	,	,	PUNCT
ajlm-289	143	9	hsi	hsi	PROPN
ajlm-289	143	10	ed	ed	PROPN
ajlm-289	143	11	,	,	PUNCT
ajlm-289	143	12	dogan	dogan	PROPN
ajlm-289	143	13	a	a	PRON
ajlm-289	143	14	,	,	PUNCT
ajlm-289	143	15	fend	fend	VERB
ajlm-289	143	16	f.	f.	PROPN
ajlm-289	143	17	plasma	plasma	PROPN
ajlm-289	143	18	cell	cell	NOUN
ajlm-289	143	19	myeloma	myeloma	NOUN
ajlm-289	143	20	and	and	CCONJ
ajlm-289	143	21	related	related	ADJ
ajlm-289	143	22	neoplasms	neoplasm	NOUN
ajlm-289	143	23	.	.	PUNCT
ajlm-289	144	1	am	be	AUX
ajlm-289	144	2	j	j	PROPN
ajlm-289	144	3	clin	clin	PROPN
ajlm-289	144	4	pathol	pathol	NOUN
ajlm-289	144	5	.	.	PUNCT
ajlm-289	145	1	2011;136(2):168–182	2011;136(2):168–182	NUM
ajlm-289	145	2	.	.	PUNCT
ajlm-289	146	1	pmid	pmid	NOUN
ajlm-289	146	2	:	:	PUNCT
ajlm-289	146	3	21757591	21757591	NUM
ajlm-289	146	4	,	,	PUNCT
ajlm-289	146	5	http://dx.doi.org/10.1309/ajcpenj68ffbriyb	http://dx.doi.org/10.1309/ajcpenj68ffbriyb	PROPN
ajlm-289	146	6	chang	chang	PROPN
ajlm-289	146	7	h	h	PROPN
ajlm-289	146	8	,	,	PUNCT
ajlm-289	146	9	qi	qi	PROPN
ajlm-289	146	10	x	x	PROPN
ajlm-289	146	11	,	,	PUNCT
ajlm-289	146	12	yeung	yeung	PROPN
ajlm-289	146	13	j	j	PROPN
ajlm-289	146	14	,	,	PUNCT
ajlm-289	146	15	reece	reece	PROPN
ajlm-289	146	16	d	d	PROPN
ajlm-289	146	17	,	,	PUNCT
ajlm-289	146	18	xu	xu	PROPN
ajlm-289	146	19	w	w	PROPN
ajlm-289	146	20	,	,	PUNCT
ajlm-289	146	21	patterson	patterson	PROPN
ajlm-289	146	22	b.	b.	PROPN
ajlm-289	147	1	genetic	genetic	ADJ
ajlm-289	147	2	aberrations	aberration	NOUN
ajlm-289	147	3	including	include	VERB
ajlm-289	147	4	chromosome	chromosome	NOUN
ajlm-289	147	5	1	1	NUM
ajlm-289	147	6	abnormalities	abnormality	NOUN
ajlm-289	147	7	and	and	CCONJ
ajlm-289	147	8	clinical	clinical	ADJ
ajlm-289	147	9	features	feature	NOUN
ajlm-289	147	10	of	of	ADP
ajlm-289	147	11	plasma	plasma	NOUN
ajlm-289	147	12	cell	cell	NOUN
ajlm-289	147	13	leukemia	leukemia	NOUN
ajlm-289	147	14	.	.	PUNCT
ajlm-289	148	1	leuk	leuk	PROPN
ajlm-289	148	2	res	re	NOUN
ajlm-289	148	3	.	.	PUNCT
ajlm-289	149	1	2009;33(2):259–262	2009;33(2):259–262	X
ajlm-289	149	2	.	.	PUNCT
ajlm-289	150	1	pmid	pmid	NOUN
ajlm-289	150	2	:	:	PUNCT
ajlm-289	150	3	18676019	18676019	NUM
ajlm-289	150	4	,	,	PUNCT
ajlm-289	150	5	http://dx.doi.org/10.1016/j.leukres.2008.06.027	http://dx.doi.org/10.1016/j.leukres.2008.06.027	PROPN
ajlm-289	150	6	chang	chang	PROPN
ajlm-289	150	7	h	h	PROPN
ajlm-289	150	8	,	,	PUNCT
ajlm-289	150	9	yeung	yeung	PROPN
ajlm-289	150	10	j	j	PROPN
ajlm-289	150	11	,	,	PUNCT
ajlm-289	150	12	xu	xu	PROPN
ajlm-289	151	1	w	w	PROPN
ajlm-289	151	2	,	,	PUNCT
ajlm-289	151	3	ning	ning	PROPN
ajlm-289	151	4	y	y	PROPN
ajlm-289	151	5	,	,	PUNCT
ajlm-289	151	6	patterson	patterson	PROPN
ajlm-289	151	7	b.	b.	PROPN
ajlm-289	152	1	significant	significant	ADJ
ajlm-289	152	2	increase	increase	NOUN
ajlm-289	152	3	of	of	ADP
ajlm-289	152	4	cks1b	cks1b	NOUN
ajlm-289	152	5	amplification	amplification	NOUN
ajlm-289	152	6	from	from	ADP
ajlm-289	152	7	monoclonal	monoclonal	NOUN
ajlm-289	152	8	gammopathy	gammopathy	ADJ
ajlm-289	152	9	of	of	ADP
ajlm-289	152	10	undetermined	undetermined	ADJ
ajlm-289	152	11	significance	significance	NOUN
ajlm-289	152	12	to	to	ADP
ajlm-289	152	13	multiple	multiple	ADJ
ajlm-289	152	14	myeloma	myeloma	NOUN
ajlm-289	152	15	and	and	CCONJ
ajlm-289	152	16	plasma	plasma	NOUN
ajlm-289	152	17	cell	cell	NOUN
ajlm-289	152	18	leukaemia	leukaemia	NOUN
ajlm-289	152	19	as	as	SCONJ
ajlm-289	152	20	demonstrated	demonstrate	VERB
ajlm-289	152	21	by	by	ADP
ajlm-289	152	22	interphase	interphase	ADJ
ajlm-289	152	23	fluorescence	fluorescence	NOUN
ajlm-289	152	24	in	in	ADP
ajlm-289	152	25	situ	situ	ADJ
ajlm-289	152	26	hybridisation	hybridisation	NOUN
ajlm-289	152	27	.	.	PUNCT
ajlm-289	153	1	br	br	PROPN
ajlm-289	153	2	j	j	PROPN
ajlm-289	153	3	haematol	haematol	NOUN
ajlm-289	153	4	.	.	PUNCT
ajlm-289	154	1	2006;134(6):613–615	2006;134(6):613–615	NUM
ajlm-289	154	2	.	.	PUNCT
ajlm-289	155	1	pmid	pmid	NOUN
ajlm-289	155	2	:	:	PUNCT
ajlm-289	155	3	16889615	16889615	NUM
ajlm-289	155	4	,	,	PUNCT
ajlm-289	155	5	http://dx.doi.org/10.1111/j.1365-2141.2006.06237.x	http://dx.doi.org/10.1111/j.1365-2141.2006.06237.x	VERB
ajlm-289	155	6	avet	avet	NOUN
ajlm-289	155	7	-	-	PUNCT
ajlm-289	155	8	loiseau	loiseau	PROPN
ajlm-289	155	9	h	h	PROPN
ajlm-289	155	10	,	,	PUNCT
ajlm-289	155	11	daviet	daviet	PROPN
ajlm-289	155	12	a	a	NOUN
ajlm-289	155	13	,	,	PUNCT
ajlm-289	155	14	brigaudeau	brigaudeau	NOUN
ajlm-289	155	15	c	c	X
ajlm-289	155	16	,	,	PUNCT
ajlm-289	155	17	et	et	PROPN
ajlm-289	155	18	al	al	PROPN
ajlm-289	155	19	.	.	PROPN
ajlm-289	155	20	cytogenetic	cytogenetic	ADJ
ajlm-289	155	21	,	,	PUNCT
ajlm-289	155	22	interphase	interphase	NOUN
ajlm-289	155	23	,	,	PUNCT
ajlm-289	155	24	and	and	CCONJ
ajlm-289	155	25	multicolor	multicolor	NOUN
ajlm-289	155	26	fluorescence	fluorescence	NOUN
ajlm-289	155	27	in	in	ADP
ajlm-289	155	28	situ	situ	ADJ
ajlm-289	155	29	hybridization	hybridization	NOUN
ajlm-289	155	30	analyses	analysis	NOUN
ajlm-289	155	31	in	in	ADP
ajlm-289	155	32	primary	primary	ADJ
ajlm-289	155	33	plasma	plasma	NOUN
ajlm-289	155	34	cell	cell	NOUN
ajlm-289	155	35	leukemia	leukemia	NOUN
ajlm-289	155	36	:	:	PUNCT
ajlm-289	155	37	a	a	DET
ajlm-289	155	38	study	study	NOUN
ajlm-289	155	39	of	of	ADP
ajlm-289	155	40	40	40	NUM
ajlm-289	155	41	patients	patient	NOUN
ajlm-289	155	42	at	at	ADP
ajlm-289	155	43	diagnosis	diagnosis	NOUN
ajlm-289	155	44	,	,	PUNCT
ajlm-289	155	45	on	on	ADP
ajlm-289	155	46	behalf	behalf	NOUN
ajlm-289	155	47	of	of	ADP
ajlm-289	155	48	the	the	DET
ajlm-289	155	49	intergroupe	intergroupe	PROPN
ajlm-289	155	50	francophone	francophone	X
ajlm-289	155	51	du	du	PROPN
ajlm-289	155	52	myélome	myélome	PROPN
ajlm-289	155	53	and	and	CCONJ
ajlm-289	155	54	the	the	DET
ajlm-289	155	55	groupe	groupe	PROPN
ajlm-289	155	56	français	français	X
ajlm-289	155	57	de	de	X
ajlm-289	155	58	cytogénétique	cytogénétique	PROPN
ajlm-289	155	59	hématologique	hématologique	NOUN
ajlm-289	155	60	.	.	PUNCT
ajlm-289	156	1	blood	blood	NOUN
ajlm-289	156	2	.	.	PUNCT
ajlm-289	157	1	2001;97(3):822–825	2001;97(3):822–825	X
ajlm-289	157	2	.	.	PUNCT
ajlm-289	158	1	pmid	pmid	PROPN
ajlm-289	158	2	:	:	PUNCT
ajlm-289	158	3	11157506	11157506	NUM
ajlm-289	158	4	,	,	PUNCT
ajlm-289	158	5	http://dx.doi.org/10.1182/blood.v97.3.822	http://dx.doi.org/10.1182/blood.v97.3.822	NOUN
ajlm-289	158	6	taniwaki	taniwaki	NOUN
ajlm-289	158	7	m	m	PROPN
ajlm-289	158	8	,	,	PUNCT
ajlm-289	158	9	nishida	nishida	PROPN
ajlm-289	159	1	k	k	PROPN
ajlm-289	159	2	,	,	PUNCT
ajlm-289	159	3	takashima	takashima	PROPN
ajlm-289	159	4	t	t	PROPN
ajlm-289	159	5	,	,	PUNCT
ajlm-289	159	6	et	et	PROPN
ajlm-289	159	7	al	al	PROPN
ajlm-289	159	8	.	.	PROPN
ajlm-289	159	9	nonrandom	nonrandom	PROPN
ajlm-289	159	10	chromosomal	chromosomal	ADJ
ajlm-289	159	11	rearrangements	rearrangement	NOUN
ajlm-289	159	12	of	of	ADP
ajlm-289	159	13	14q32.3	14q32.3	NUM
ajlm-289	159	14	and	and	CCONJ
ajlm-289	159	15	19p13.3	19p13.3	NUM
ajlm-289	159	16	and	and	CCONJ
ajlm-289	159	17	preferential	preferential	ADJ
ajlm-289	159	18	deletion	deletion	NOUN
ajlm-289	159	19	of	of	ADP
ajlm-289	159	20	1p	1p	NUM
ajlm-289	159	21	in	in	ADP
ajlm-289	159	22	21	21	NUM
ajlm-289	159	23	patients	patient	NOUN
ajlm-289	159	24	with	with	ADP
ajlm-289	159	25	multiple	multiple	ADJ
ajlm-289	159	26	myeloma	myeloma	NOUN
ajlm-289	159	27	and	and	CCONJ
ajlm-289	159	28	plasma	plasma	NOUN
ajlm-289	159	29	cell	cell	NOUN
ajlm-289	159	30	leukemia	leukemia	NOUN
ajlm-289	159	31	.	.	PUNCT
ajlm-289	160	1	blood	blood	NOUN
ajlm-289	160	2	.	.	PUNCT
ajlm-289	161	1	1994;84(7):2283–2290	1994;84(7):2283–2290	NUM
ajlm-289	161	2	.	.	PUNCT
ajlm-289	162	1	pmid	pmid	NOUN
ajlm-289	162	2	:	:	PUNCT
ajlm-289	162	3	7919347	7919347	NUM
ajlm-289	162	4	.	.	PUNCT